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“I know that my work is a drop in the ocean, but without 
it, the ocean would be smaller” 
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RESUMO 
 
Os doentes com cancro apresentam um enfraquecimento do sistema imunológico, 
onde a imunidade inata, responsável pela detecção precoce e eliminação das células 
malignas se encontra deficiente. Estudos recentes sobre as células NK, que parecem 
constituir a primeira linha de defesa contra as células tumorais, apontam para uma 
correlação entre a diminuição da sua atividade e a presença de um pior prognóstico. De 
acordo com Chen (2002), existe uma correlação positiva entre a prática de Qigong e o 
melhoramento do sistema imunitário, traduzindo-se numa melhoraria da deficiência 
imunológica apresentada pela maioria dos doentes com cancro. 
Qigong, um dos métodos terapêuticos da Medicina Tradicional Chinesa, apresenta-
se como uma terapia de biofeedback vegetativo. É uma prática corpo-mente desenvolvida 
há mais de 5000 anos, que surge através da combinação de exercícios físicos e meditação, 
no sentido de harmonizar o corpo, mente e espírito. Tem efeitos ao nível emocional e 
psíquico assim como ao nível físico e imunológico.  
Objetivos: : 1) Avaliar o efeito do Qigong no sistema imunitário, especificamente 
nas células NK e na qualidade de vida dos doentes com CCR. 2) Fundamentar a aplicação 
de técnicas de Qigong bem como a eficácia de um exercício específico de Qigong ("Happy 
Qigong") na estimulação do sistema imunitário; 3) Demonstrar a viabilidade desta terapia 
em ambiente hospitalar e em doentes com CCR. 
Métodos: Estudo prospetivo, randomizado e controlado. 
Foram recrutados doentes com CCR através da Clínica de Patologia Digestiva 
integrada no Instituto Português de Oncologia do Porto (IPO). Os doentes foram 
randomizados em dois grupos; intervenção de (n = 10) e grupo control (n = 10). Os doentes 
do grupo experimental receberam 6 sessões de terapia de Qigong, duas vezes por semana 
durante os tratamentos de quimioterapia. A terapia de Qigong aplicada é baseada no 
Modelo de Heidelberg de MTC. As amostras de sangue foram colhidas no início do estudo 
(T0) que corresponde ao sétimo dia após a sessão de quimioterapia e as seguintes 
amostras são colhidas uma vez por semana durante um período de 3 semanas. O grupo 
de control teve apenas de recolher as amostras de sangue para o estudo sem receber 
qualquer tratamento de Qigong. 
Parâmetros primários: Hemograma completo; linfócitos T e B e células NK 
quantificados por citometria de fluxo.  
Parâmetros secundários: Avaliação dos níveis de ansiedade e depressão bem 
como a qualidade de vida (QOL).  
Análise estatística: Os resultados serão analisados dentro de cada grupo e entre 
os grupos (antes e depois da intervenção). 
  
Discussão: Serão comparados dados acerca da quantificação das células NK nos 
dois grupos. Os dados sugerem que o Qigong pode ter um papel mieloprotetor, reduzindo 
as taxas de leucopenia, neutropenia e do estado psicoemocional nos pacientes submetidos 
a quimioterapia com CCR. 
Conclusão: O tratamento de Qigong baseado no Modelo de Heidelberg fornece 
indícios que pode promover o aumento das células NK, o qual possivelmente se poderá 
traduzir na melhoria do sistema imunológico, bem como, numa melhoria da qualidade de 
vida nos doentes com CCR. 
 
 
Palavras-chave: Cancro colo-retal, Quimioterapia, Medicina Chinesa, Qigong, 
Sistema imunitário. 
 
 
 
 
 
 
  
  
ABSTRACT 
 
Cancer patients suffer from a weakened immune system where innate immunity, 
responsible for the early detection and elimination of malignant cells, is inefficient. The 
development of NK cells, which appears as the first line of defense against tumor cells, 
points to a correlation between the reduction in their activity and the presence of a worse 
prognosis. Accordingly to Chen (2002) and Cai et al( 2001) Qigong produce an 
improvement of the immune function, which may enhance the immune deficiency 
experienced by most of cancer patients and the improve of the microcirculatory functions. 
Qigong, one of the therapeutic methods of Traditional Chinese Medicine, presents 
itself as a vegetative biofeedback therapy. It is a mind-body practice developed more than 
5000 years, which are the combination of physical exercises and meditation in order to 
harmonize body, mind and spirit. Has specific emotional control, fatigue, nausea, 
stimulation of the immune system, among other exercises.  
Objective: 1) To evaluate the effect of Qigong on the immune system, specifically 
in NK cells and the quality of life of patients with Colo- rectal cancer (CRC). 2) Justify the 
application of techniques of Qigong and the effectiveness of specific exercise Qigong 
('Qigong Happy ") in the stimulation of the immune system; 3) Demonstrate the feasibility 
of this therapy in the hospital in patients with CRC. 
Methods: A prospective, randomized and controlled study. CRC patients recruited 
from Clinic of Digestive Pathology integrated in the Portuguese Oncology Institute of Porto( 
IPO). They were randomized in two group intervention (n=10) and control group (n=10). 
Patients in the experimental group received 6 sessions of Qigong therapy, twice a week  
between the chemotherapy protocol. Treatment protocol based on the Heidelberg Model of 
TCM. Blood samples will be collected at baseline (T0) on the day prior to chemotherapy 
and the following samples are collected every once a week until next chemotherapy (CT) 
regimen. The control group just been collecting the blood sampling for the study without 
receiving any Qigong treatment. 
Primary Outcome: Complete Blood counts, T and B lymphocytes, NK cells by 
flow cytometry.  
Secondary Outcomes: Assessment of anxiety and depression levels as well as 
quality of life.  
Statistical analyses: Results will be analyzed within each group (before and after 
intervention) and co- relational comparison between groups. 
Discussion: Two studies have addressed on NK cells subset activity in cancer 
patients. Based on our results, they suggest that Qigong may have a myeloprotective role 
  
by reducing the rates of leukopenia and neutropenia in CRC patients undergoing 
chemotherapy. 
Conclusion:.The Qigong treatment based on Heidelberg Model provides evidence 
that can promote the increase of NK cells, which possibly can be translated in improving 
the immune system, as well as an improvement of quality of life in patients with CRC. 
 
 
Keywords: Colorectal Cancer, chemotherapy, Chinese medicine, Qigong, immune 
system. 
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INTRODUCTION 
 
 
According to an estimate of the World Health Organization (WHO), cancer is a 
leading cause of death worldwide, accounting for 8.2 million deaths in 2012, whereas 
colorectal cancer occupies the 3rd position in the ranking, with the highest rate of deaths in 
Portugal [1]. In Portugal, the incidence of CRC is almost similar in both genders, although 
Colon cancer is slightly more common in women and Rectal cancer in men [2]. According 
to data retrieved from the Northern Regional Cancer Registry, in 2006, from the 5171 
diagnosed malignant tumors, 311 (6%) were colon and 387 (7.5%) rectal diagnosis [3]. 
The choice of this study`s subject results from the fact that cancer is one of the most 
common chronic diseases and is currently considered one of the main health problems of 
the twenty-first century and it will be the next global concern regarding the health of the 
population. Furthermore, cancer will be in the top of the scientific research and technology 
advances. The current available practices for CRC treatment include: surgery, 
chemotherapy, radiotherapy as well as new antiangiogenic drugs, which are not always 
100% effective. 
It is common sense that chemotherapy (CT) induces immunosuppression, local or 
systemic, and that may adversely affect the formation, recruitment and action of effector 
cells of the immune system and thus precipitate a therapeutic failure.  
Some studies have confirmed the effectiveness of a multidisciplinary treatment of 
oncological diseases; it seems that combining treatments is more successful than the 
proposed one-dimensional treatment. It is important for patients to have at their disposal 
multidisciplinary team acting in different ways and perspectives, so they can have an 
integrated view of the patient as a whole. For instance, Graner (2010) considered that, 
complementary and alternative therapies aim to reduce symptoms and promote quality of 
life in different stages of treatment concomitantly to clinical usual. [4] 
In this context, arises the importance of Qigong in cancer treatment because many 
studies suggest that Qigong therapy and Qigong practice may help cancer patients improve 
their immune functions as well as improving the physical and psychological well-being. In 
fact, health promotion and disease prevention have been the basis for life conditions 
improvement. 
The main purpose of this study is to evaluate the effects of Qigong in the immune 
system, particularly NK cell and quality of life of patients with CRC. 
This work is divided in two parts. The first part contextualizes the problem, which 
presents the theoretical background since its concept; the second part presents the 
methodological framework and research results. 
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1. CANCER - IMMUNOLOGICAL ASPECTS 
 
 
The last 20 years have seen a reemergence of interest for the immunological 
aspects of cancer and how the immune system behaves. 
The concept that the Immune System protects the host against cancer was first 
proposed by Erlich in 1909 and modified in the 1950s by Burnet and Thomas. 
Cancer is widely considered to be a cell-autonomous genetic disease that results 
from alterations in oncogenes, tumor-suppressor and genome-stability genes. However, the 
tumor-cell microenvironment and immunity also have a major role in cancer process. Four 
classes of cells have been established to have key roles in the immune response against 
tumors, andconsequently the Immune system is totally involved in this action. These cells 
are: Natural Killer (NK) cells, that provide innate immune response; CD8+ T lymphocytes, 
that represent the adaptive immune response and NK cells. 
To win the fight against cancer, it is necessary not only to develop strategies to kill 
all cancer (stem) cells efficiently, by using the correct combination and schedule of 
chemotherapeutic agents, but also to attempt to stimulate an immune response so that the 
immune system can keep residual tumor cells in check.  
It is supported by a strong experimental data derived holds that the immune system not only 
protects the host against development of primary nonviral cancers but also scupts tumor 
immunogenicity [5]. Cancer immunoediting is a tumor suppressor mechanism that engages 
only after cellular transformation has occurred and intrinsic tumor suppressor mechanisms 
have failed. In its most complex form, cancer immunoediting consists of three phases: a) 
elimination phase, in which cancer cells are recognized by the immune system and may be 
eradicated; b) equilibrium phase appears if elimination is unsuccessful, and immune system 
and cancer cells achieve an equilibrium in which cancer is contained but not eliminated and 
c) the escape phase appears when the tumor evades the effector mechanisms of the 
immune system and proliferates without control [6]. 
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Figure 1: Cancer immunoediting theory. Diverse immune cells involved in the 
different phases. Data from Robert Strausberg et all. (2011) [7] 
 
 
The immune system’s capacity to destroy and shape cancer is a process that makes 
cancer under control for long periods of time by a process called equilibrium. This is a 
component of cancer immunoediting where cells have a highly immunogenic and this 
process occurs between elimination and escape phases. Whereas elimination requires 
elements from both the innate and the adaptive immune response attenuated 
immunogenicity [7]. 
 
 
1.1 - NK CELLS AND THE IMMUNE SYSTEM 
 
The immune system is classically divided into innate and adaptive immunity.  
The innate system is composed mainly of NK cells, polymorphonucleocytes (PMN) and 
macrophages, and is most directly involved in tumour immunology. These cells also 
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participate in the adaptive response and form an important and vital bridge between the two 
arms of the immune system. 
Natural killer (NK) cells “sit” between innate and adaptive immunity and represent a 
subgroup of white blood cells and were originally defined as effector lymphocytes of innate 
immunity with constitutive cytolytic funtions. NK cells are constantly patrolling the body. As 
effectors members of the innate immunity, they can directly kill target cells without prior 
activation, priming or assistance by cytokines. NK cells have been recognized as major 
producers of cytokines in many physiological and pathological conditions, such as IFNγ, 
tumour necrosis factor (TNF alfa) and interleucine (IL)-10. 
The production of IFNγ is related with the modulation of T cell responses possibly 
by a direct interaction between T cells and NK cells migrating from inflamed peripheral 
tissues to secondary lymphoid compartments.  NK cells modulate emerging B and T cells 
and are also regulatory cells engaged in reciprocal interactions with Denditric cells (DC), 
macrophages, T cells and endothelial cells. In consequence, they achieve their full effector 
potential, highlighting the intimate regulatory interactions between NK cells and other 
components of immune response. 
 
 
 
Figure 2: The biological functions of NK cells 
Data from Robert D. Schereiber (2001) [8]. 
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In resume, they are an effective mechanism for controlling potential infections with 
a sophisticated biological function and preventing cancer progression. 
 
1.2 - NK CELLS IN CANCER IMMUNITY 
 
In 1909, a scientist by the name of Paul Ehrlich proposed that the incidence of 
cancer would be much greater were it not for the vigilance of our immune defense system 
in identifying and eliminating tumor cells. The immune system has a major role in the 
prevention of tumors. Initially, the immune system can protect the host from virus-induced 
tumors by eliminating or suppressing viral infections. Consequently, the timely elimination 
of pathogens and prompt resolution of inflammation can prevent the establishment of an 
inflammatory environment conducive to tumorigenesis, so the immune system can 
specifically identify and eliminate tumor cells on the basis of their expression of 
tumor-specific antigens or molecules induced by cellular stress. 
Several studies verified that the lack of NK cells or molecules associated with NK 
cells recognition or effector function in mice was associated with an increase of tumor 
incidence [9]. 
NK cells are considered to represent a first line of defense against the metastatic 
spread of tumor cells. This idea is supported by the report of an association between the 
decreased activity or low numbers of circulating NK cells with progression of cancers; and 
a correlation between an absolute decrease in the activity of the NK cells and an absolute 
decrease in the lytic potential of these cells [9]. Consequently, NK cells are the first cells 
identified for their ability to kill tumor cells without deliberate immunization or activation [10]. 
Some activating NK cell receptors and costimulatory molecules have been identified 
that permit these cells to recognize tumors and virus-infected cells and destroy them. Two 
major mechanisms are used to induce target cells apoptosis: granule exocytosis and death 
receptor stimulation. Granule exocytosis envolves the release of perforine and granzymes 
while the death receptor pathway is largely mediated by apoptosis inducing members such 
as TNF (alfa) and LT [11]. When NK cells detect an infected or tumor cell, they secrete 
granules that contain perforin, creating a pore in the target cell; granzymes then pass 
through these pores, degrading cellular proteins, causing cells to undergo apoptosis.  
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Fig.3: Schematic presentation of cytotoxicity of NK role in cancer cells 
Data from: Medical Research Council [70]. 
 
 
These cells are modulated by an inhibitory receptors that sense the levels of major 
histocompatibility complex (MHC) class I on prospective target cells to prevent unwanted 
destruction of healthy tissues. Their cytotoxic ability can be enhanced by cytokines, such 
as interleukin (IL) -2, IL-12, IL-15 and interferon alpha/beta (IFN-alpha/beta) [10]. 
In conclusion, data review show that the loss of immune competence, more precisely 
the lower levels and/ or activity of NK cells, is considered an important cancer risk factor 
and allows to conclude that NK cells participates in immunosurveillence against certain 
types of tumors [10]. 
 
 
1.3 - IMMUNE PARAMETERS CORRELATED WITH THE EFFICACY OF CHEMOTHERAPY 
 
Conventional anticancer chemotherapy has been historically thought to act through 
direct killing of tumor cells. Accumulating evidence indicates that the innate and adaptive 
immune systems make a crucial influence to the antitumor effects of conventional CT 
cancer treatment. This concept stems from the fact that cytotoxic drugs interfere with DNA 
synthesis and replication. Several direct effects of cytotoxic drugs have been described for 
macrophages, DC and NK cells. Earlier studies on NK cells function in cancer patients 
undergoing cytotoxic CT have shown variable effects, especially in correlation with the 
clinical outcome [12]. However, this fact indicates that the antitumor activities of CT also 
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rely on several off-target effects, especially directed to the host immune system, that 
cooperate for successful tumor eradication [13]. Beyond cancer-cell-intrinsic factors that 
determine the cytotoxic or cytostatic response, as well as the potential immunogenicity of 
tumor cells, the functional state of the host immune system has a major prognostic and 
predictive impact on the future of cancer patients treated with conventional or targeted 
chemotherapies [14]. Chemotherapeutic agents stimulate both the innate and adaptive 
arms of the immune system. The outcomes of CT can promote specific adjustments on 
dying tumor cells, which render them visible to the immune system. It is becoming evident 
that CT agents can deeply have an impact on both tumor and host immune system. Some 
cytotoxic drugs have been shown to induce an immunogenic type of cell death in tumor 
cells, resulting in the emission of specific signals that trigger phagocytosis of cell debris and 
promote the maturation of dendritic cells, ultimately resulting in the induction of potent 
antitumor responses. [13] 
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2. COLO RECTAL CANCER OVERVIEW 
 
 
 Colorectal cancer is one of the most common malignancies in developed countries. 
In the vast majority of cases, it is sporadic, but can also be hereditary, as familial 
adenomatous polyposis and colorectal cancer hereditary non polyposis. Colon 
cancer mostly arises from adenomas, recognized as colonic polyps, but may occasionally 
arise from the sessile serrated adenoma. Adenomatous polyposis coli (APC) gene mutation 
is the key molecular step in adenoma formation.   
 
 
 
Fig 4- Colon rectal cancer overview 
Data from Medical Research Council [70]. 
 
Those with a personal history of adenomas or CRC are at increased risk. Individuals 
with a family history of CRC or adenomas, various genetic polyposis and nonpolyposis 
syndromes and inflammatory bowel disease are also at higher risk of developing CRC. 
Progression from adenomas to colon cancer is a multistep process.  In fact, when the 
process of the normal replacement of lining cells goes awry, some mistakes in mucosal cell 
division frequently occur that escape from our editing systems. When this occurs, these 
cells begin to divide independently of the normal checks and balances that control growth. 
Over 95% of colon and rectal cancers are adenocarcinomas and most of the patients have 
no identifiable genetic risk factors [15]. These are cancers that start in gland cells, like the 
cells that line the inside of the colon and rectum. There are some other, more rare, types of 
tumors of the colon and rectum that we discuss below. 
 
 
EFFECT OF QIGONG IN NATURAL KILLER CELLS ON COLO-RECTAL CANCER PATIENTS UNDERGOING FOR 
CHEMOTHERAPY 
 
 
26 
 
2.1 - EPIDEMIOLOGY, ETHIOLOGY AND PATHOPHYSIOLOGY 
 
Colorectal cancer is the 3rd most common form of cancer worldwide, with 
approximately one million new cases diagnosed each year. Data from GLOBOCAN, 2008 
report by the International Agency for Research on Cancer (IARC) shows that colorectal 
cancer is the third most common form of cancer in men (663,000 cases, 10% of the total) 
and the second most common in women (570,000 cases 9.4% of total) worldwide [16]. 
According to the WHO, the CRC is the most common cancer in the European Union. 
About 4% of European men and 3% of European women develop CCR up to 75 years [1].  
The CRC it is a global health problem with an annual incidence of approximately 
1000000 cases and more than 500,000 cases per year of mortality [18]. In Portugal, the 
incidence of CRC is almost similar in both sexes, although the colon cancer is slightly more 
common in women and cancer of the rectum in men [17]. According to the Northern 
Regional Cancer Registry (RORENO) in 2006 of malignant tumors diagnosed 5171, 311 
(6%) were colon and 387 (7.5%) of the rectum [19]. In concern to mortality, the country with 
the highest rate of mortality is Hungary and Greece to the lowest for both sexes. Portugal 
is in 7th position for males and sixth for females [20]. 
In Portugal CRC mortality has increased significantly in recent decades, with an 
average annual rate of 4%. In 1999 the CRC was responsible for 2828 deaths and 
considered the leading cause of cancer death in that year [21]. According to statistics, in 
2005 the mortality rate for CCR was 14.6%, corresponding to 3319 deaths per year and 
more than nine deaths per day. CCR is currently the leading cause of death from 
malignancy in Portugal, only that the Western world [22]. 
In fact, in most countries there has been a decrease in the rate with the exception 
of Korea, Portugal, Slovenia, Poland, Mexico, Greece, Chile and Estonia [23]. 
The progress of CRC has been associated with several important risk factors, which 
can be grouped in two main groups: the “environmental” factor group and the genetics factor 
group [24]. The findings from epidemiologic studies that physical inactivity, excess of body 
weight and a central accumulation of adiposity have an influence on CRC risk, as well as 
the ethnic and racial differences in the CRC and studies on migrants suggest that an 
environmental factor plays an important role in a etiology of this disease. 
In fact, diet is considered an important factor of increased risk of the development 
of CRC, playing a significant role in determining the incidence of CRC in the general 
population. Compelling evidence suggests a strong dose-related association between red 
meat and fat intake and the development of CRC; and higher cholesterol values correlate 
significantly with the later tumor development. On the other hand, diets rich in vegetables 
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and high fiber grains as well as the consumption of fish and skinless chicken demonstrate 
a protective effect in the pathophysiology of CRC. 
As a genetic factor group, patients who have familial adenomatous polyposis (FAP), 
who have medical history of adenomatous colonic polyps, inevitably develop colon cancer 
if colectomy is not performed [25]. The FAP syndrome accounts for approximately 1% of all 
CRC cases and patients will most likely present with adenocarcinoma before the age of 40. 
This syndrome is inherited as a classic Mendelian single autosomal dominant gene. 
Patients who have FAP carry this germline mutation in one allele in all somatic cells, 
including colonocytes. Therefore, prophylactic colectomy is recommended at an early age 
for FAP patients. Gardner’s syndrome is a rare phenotypic variant of FAP, both caused by 
mutation in the APC gene. In addition to colon polyposis, Gardner patients acquire extra-
colonic tumours including osteomas, thyroid cancer, epidermoid cysts, fibromas, sebaceous 
cysts and desmoids tumours. The disease is not curable and life expectancy with the 
condition is 35-45 years [26]. Patients with inflammatory bowel disease with long evolution 
have also more prone to develop CRC and have the indication for periodic surveillance [27]. 
 
2.2- CLINICAL PRESENTATION – SIGNS AND SYMPTOMS 
 
Patients with CRC may present in three ways: patients with suspicious symptoms 
and/or signs; asymptomatic individuals discovered by routine screening; and emergency 
admission with intestinal obstruction, peritonitis, or rarely, an acute gastrointestinal bleed. 
Colon cancer also tends not to produce signs until advanced [28]. Some clinical 
signs are anemia from gastrointestinal bleeding that produce pallor, iron deficiency anemia, 
spooned nails, glossitis manifested by lingual erythema and papillae loss. 
Hypoalbuminemia may manifest clinically as peripheral edema, ascites, or anasarca. Rectal 
cancer may be palpable by digital rectal examination. Although colon cancer previously was 
believed to frequently cause fecal occult blood as detected by stool guaiac tests. 
Symptoms are common and prominent late in colon cancer when the prognosis is 
poor but are less common and less obvious early in the disease. Common symptoms are 
listed in Table 1. Less common symptoms include nausea and vomiting, malaise, anorexia, 
and abdominal distention [29]. Although colon cancer can present with diarrhea or 
constipation, a recent change in bowel habits more likely is from colon cancer than 
chronically abnormal bowel habits. 
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Symptoms associated with colon cancer 
 
Symptoms Frequency 
       Abdominal Pain 
44% 
 
             Change in bowel habit 
43% 
 
  Hemtochezia or melena 
40% 
 
   Weakness or malaise  
 
20% 
 
             Involuntary weight loss 
16% 
 
 
Table 1. Symptoms associated with CRC and respectively frequency 
Extrated from Camppell MS.(1992) [28]. 
 
Symptoms depend on the cancer location, size, and presence of metastases. A 
change in bowel habits is generally an indicator of left-sided than right-sided CRCs because 
fecal contents are liquid in the proximal colon and the lumen caliber is larger, and they are 
therefore less likely to be associated with obstructive symptoms; Hematochezia is more 
often caused by rectosigmoid than right-sided colon cancer; Iron deficiency anemia is more 
common with right-sided CRCs. Ascending colon tumors have a fourfold higher mean daily 
blood loss (approximately 9 ml/day) than tumors at other colonic sites [28-30]. 
Abdominal pain can occur with tumors arising at all sites; it can be caused by a 
partial obstruction, peritoneal dissemination, or intestinal perforation leading to generalized 
peritonitis. Advanced cancer, particularly when metastatic, can involuntary weight loss, 
anorexia, muscle weakness, and a feeling of poor health. 
 
 
2.3 - SCREENING AND PREVENTION 
 
The CRC may be suspected from one or more of the symptoms and signs described 
above or may be asymptomatic and discovered by routine screening of average and high-
risk subjects. Screening for the prevention and early detection of CRC is crucial to improve 
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one's chances against colon cancer. Screening has led to a decline in the number of deaths 
from colon cancer over the last 20 years. Early detection is essential to ensure survival if 
cancer is found. 
 
FOBT is a non-invasive mean of diagnosing and relatively simple used in clinical 
practice. The main drawbacks are the low sensitivity of the method, that allows the diagnosis 
in an advanced stage, since bleeding tends to occur lately in the progression of the disease 
and does not allow to distinguish the origin of the hematic loss. Since the bleeding may be 
intermittent, FOBT may be negative in 50% of patients with CRC, this creates a limitation in 
this technique. However, a patient with positive FOBT must be submitted to a study with 
sigmoidoscopy, barium enema and / or colonoscopy. 
Once a CRC is suspected, the first line exam for the study of the CRC is the 
colonoscopy. A prospective study that considered 13580 colonoscopies performed by 
surgeons in the United States found that the rate of complications associated with the 
technique is low, occurring in drilling 0:02% of cases undergoing diagnostic colonoscopy, 
bleeding in  0:19% and perforation at 0.15% of cases with therapeutic colonoscopy [31]. 
This single test, which usually takes an hour or less to complete, may be both diagnostic 
and therapeutic. The sensitivity level of colonoscopy is such that it can detect polyps greater 
than or equal to one centimeter in size. More than 95% of tumors are detected during a 
colonoscopy. Colonoscopy is the preferred procedure for the diagnosis of symptomatic 
patients. At the present time, it is the best diagnostic tool for the diagnosis of colorectal 
neoplasia [32]. 
 
Fig 5 . Colonoscopy – Endoscopic views and biopsy technique 
Data from Johns Hopkins Medicine [32].  
 
Sigmoidoscopy is another method used in the endoscopic diagnosis of CCR, 
allowing visualization of the colon up to 60 cm [27]. About 70 to 85% often allows 
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identification of the tumor at its most usual location. However, not allowing the study of the 
proximal part of the large intestine. 
Barium enema is widely available and may be used to investigate patients with 
symptoms suggesting of CRC. Is a radiological examination of the rectum and the entire 
colon and has been used for many years to diagnose polyps and colon cancers. The 
complication rate with the procedure is very low; the rate of perforation is one in 25,000 
examinations [32]. However, the diagnostic yield of both double-contrast barium enema 
(DCBE) alone and the combination of DCBE plus flexible sigmoidoscopy is less than that 
of colonoscopy or CT colonography for the evaluation of lower tract symptoms. After 
detection by barium enema of a polyp or a mass, colonoscopy is recommended to establish 
the histology, remove the polyp, and search for synchronous lesions. 
CT colonography (virtual colonoscopy or CT colography) provides a computer-
simulated endoluminal perspective of the air-filled distended colon. CT colonography 
requires a mechanical bowel preparation that is similar to that needed for barium enema, 
since stool can simulate polyps. CT colonography should be restricted to patients who are 
able to pass flatus and capable of tolerating the oral preparation. For clinically obstructed 
patients, a gastrointestinal (GI) CT scan is a good alternative to CT colonography.  
Resuming, the CT colonography provides a similarly sensitive, less invasive 
alternative to colonoscopy in patients presenting with symptoms suggestive of CRC. 
However, since colonoscopy permits removal/biopsy of the lesion and the detection of any 
synchronous cancers or polyps, colonoscopy seems to constitute the gold standard for 
investigation of symptoms suggestive of CRC. 
Thus, the principal of the program of screening the CRC, have as an objective the 
diagnosis of the disease at early stages, taking into account  the potential risk of an 
individual developing the disease, based on various parameters, such as age, family and 
personal history of CRC or prior colorectal adenoma, as well as a history of inflammatory 
intestinal disease [33]. 
The screening can be divided into two groups: in the general population (group low 
risk) and of individuals with increased risk of family history of CRC staff or adenomatous 
polyps or colorectal inflammatory intestinal disease. Various entities such as the American 
Cancer Society, the American College of Gastroenterology and American Society of Colon 
and Rectal Surgeons recommend, for screening individuals over 50 years with no risk 
factors, the annual realization of FOBT and / or flexible sigmoidoscopy every 5 years or 
double contrast barium enema every 5 years or  colonoscopy  from 10 to 10 years [34]. The 
rectal examination should also be done in individuals over the age of 40 years [27]. 
Individuals with a family history of CRC are a group of high risk. For patients with a 
first-degree relative who was diagnosed with the disease before age 45 or with two family 
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first degree affected, the risk of developing this cancer rises to 1 in 10 individuals. In these 
patients should be recommended screening with a low starting age 10 years earlier than 
that endoscopy the affected family had when he was diagnosed [35]. 
A variety of serum markers have been associated with CRC, particularly 
carcinoembryonic antigen (CEA). Currently in Europe, the guidelines indicate its use only 
the follow-up of patients undergoing surgery as a way to detect recurrence early, and, 
nevertheless, a high rate of false negatives [36]. Despite being a disease with high morbidity 
and mortality, the process of oncogenesis is relatively long (5 to 10 years) and the presence 
of lesions benign precursors (normal mucosal dysplasia, adenoma, carcinoma) offer a 
window for therapy before the development of a malignancy, contributing to an increase in 
cure rates [36 e 37]. 
 
 
2.4 - CRC STAGING 
 
After the establishment of the diagnosis is important to determine the extent of 
disease either locally or at a distance [38]. Staging can be clinical or pathological. While 
there are several systems, Tumor-node-metastasis (TNM), defined by the American Joint 
Committee on Cancer, is the most widely used for staging of CRC [34 and 39]. The letter T 
represents the depth of penetration of the tumor, N defines the achievement of lymph nodes 
and the presence of M distant metastases[39, 40]. As is represented on the table below, 
the tumor is first scored with respect to the TNM variables  and then assigned to stage I-IV 
in the CRC specifically [41- 43]. 
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TNM STAGE 
 
 
T- Primary tumor 
DISEASE EXTENSION 
Tx 
Primary tumour cannot be assessed 
 
T0 
No evidence of primary tumour 
 
Tis 
Carcinoma in situ: intraepithelial or invasion of 
lamina propria 
 
T1 
Tumour invades submucosa 
 
T2 
Tumour invades muscularis propria 
 
T3 
Tumour invades through the muscularis propria into 
pericoloretal tissues 
 
T4a) 
Tumor penetrates to the surface of the visceral 
peritoneum 
 
T4b) 
Tumor directly invades or is adherent to other organs 
or structers 
 
Table. 2. TNM classification System  
Data from American Joint Committee of  Cancer (2009) [15]. 
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TNM STAGE 
 
N-Regional Lymph Nodes 
DISEASE EXTENSION 
Nx Regional lymph nodes cannot be assessed 
N0 
No regional lymph node metastasis 
 
N1 
Metastasis in 1-3 regional lymph nodes 
 
N1a) 
Metastasis in one regional lymph node 
 
N1b) 
Metastasis in 2–3 regional lymph nodes 
 
N1c) 
Tumor deposit(s) in the subserosa, mesentery or 
nonperitonealized pericolic or perirectal tissues 
without regional nodal metastasis 
 
N2 
Metastasis in 4 or more regional lymph nodes 
 
N2a) 
Metastasis in 4–6 regional lymph nodes 
 
N2b) Metastasis in 7 or more regional lymph nodes 
 
Table 3. TNM classification System 
Data from American Joint Committee of  Cancer (2009) [15]. 
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TNM STAGE 
 
M–Distant Metastasis 
DISEASE EXTENSION 
M0 
No distant metastasis 
 
M1 
Distant metastasis 
 
M1a) 
Metastasis confined to one organ or site 
(for example, liver, lung, ovary, nonregional node) 
 
M1b) 
Metastases in more than one organ/site or the 
peritoneum 
 
Table 4. TNM classification System 
Data from American Joint Committee of  Cancer (2009) [15]. 
 
 
The prognosis of patients with CRC depends on tumor invasion in the intestinal wall, 
the involvement of local lymph nodes and distance metastases; it is only possible to define 
precisely the stage of the disease in the pos-operative phase, except when there is 
evidence of distant metastasis [41]. 
 
 
2.5- CONVENTIONAL TREATMENT APPROACH 
 
The therapeutic approach to CRC involves, in most cases surgery, chemotherapy 
and radiotherapy as well as new anti-angiogenic drugs. The different therapeutic options 
vary according to tumor staging - size, location and metastasis, as well as the physical 
condition of the patient. 
Cancer treatment has gone through a slow process of development. It was in the 
19th and early 20th centuries that major advances were made in general surgery and cancer 
surgery. During the final decades of the 20th century, surgeons developed greater technical 
expertise in minimizing the amounts of normal tissue removed during cancer operations. 
This progress depends not only on understanding cancer better as a disease and on better 
surgical instruments, but also on combining surgery with other kinds of treatments such as 
chemotherapy and radiation. 
EFFECT OF QIGONG IN NATURAL KILLER CELLS ON COLO-RECTAL CANCER PATIENTS UNDERGOING FOR 
CHEMOTHERAPY 
 
 
35 
 
2.5.1 - SURGERY 
 
Surgery is the main treatment of CRC, which aims, regardless of the location of the 
tumor, the removal of the primary tumor adequate margins and conducting regional 
lymphadenectomy, and generally accepted that at least 12 nodes must be isolated for 
Correct staging tumor [46]. Approximately 92% of patients with colon cancer are subjected 
to surgery, as a first treatment option, mostly with curative intent [47]. For stage 0 (Tis N0 
M0, T1 N0 M0), the treatment options include: a) local excision or simple polypectomy; b) 
segmentary resection for larger lesions not amenable to local excision. Treatment of stage 
I (T2 N0 M0) tumours consist in a wide surgical resection and anastomosis. For stage II (T3 
N0 M0, T4 N0 M0) the standard treatment options include: a) wide surgical resection and 
anastomosis; b) after surgery, in high-risk patients adjuvant therapy could be considered. 
And for stage III (any T, N1 M0, any T, N2 M0) the treatment options are a) extensive 
surgical resection and anastomosis; b) after surgery the standard treatment is a doublet 
schedule with oxaliplatin and 5FU/folinic acid (LV) (FOLFOX4 or FLOX) [45]. Advances in 
surgical technique have increased the percentage of patients with potentially curable 
disease. These developments included the development of techniques such as block 
resection, total excision of the mesorecto for rectal carcinoma, laparoscopy and the 
technique of "no-touch" which aims at limiting the spread throughout the tumor vascular 
operative time. Laparoscopy is currently seen as a good alternative .The classical 
treatment, with the advantage that the need for shorter of hospital stay, less pos-operative 
pain and earlier recovery intestinal function. There is however, some controversy regarding 
possibility of intraperitoneal dissemination and hematogenous cells neoplastic with this 
surgical technique, with some studies pointing one increased risk of spreading when the 
laparoscopy is compared with the open surgery and other studies disagree with such fact 
[46]. 
Regarding colorectal cancer, the surgical treatment depends on the location of 
neoplasia. The proximal and middle rectal tumors are usually underwent low anterior 
resection with anastomosis primary, an ileostomy or colostomy may be necessary in the 
past temporary to facilitate healing, to divert the flow of fecal anastomosis. For tumors of 
the distal rectum amputation is indicated abdominoperitoneal with permanent colostomy 
and in cases where it is not possible to keep sphincter [39]. 
Advances in surgical techniques, has made it possible for patients with metastatic 
RCC, surgery may have a curative character. Patients with resectable liver metastases 
should undergo partial hepatectomy, thus achieving a survival at 5 years 25-30% [40]. 
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2.5.2 - RADIOTHERAPY 
 
Radiotherapy is a treatment commonly used against cancer. The benefits of 
radiation therapy for patients with colorectal cancer include: a) killing and eliminating cancer 
cells and tumors; b) shrinking tumors; c)  preventing cancer cells from growing and dividing. 
The DNA of a malignant cell is more susceptible to radiation damage than a normal cell. 
Radiation used before surgery to shrink a tumor can provide the best chance of successful 
tumor removal during surgery. Radiation administered after surgery can eliminate remaining 
cancer cells.  Radiation therapy began with radium and with relatively low-voltage diagnostic 
machines. Methods and machines for delivery of radiation therapy have steadily improved. 
Nowadays, radiation is delivered with great precision to destroy malignant tumours and 
controlling damage to nearby normal tissues [15]. Radiation therapy is typically combined 
with chemotherapy, such as the drug, 5-FU. Adding chemotherapy to the radiation therapy 
improves the effectiveness of the treatment by making the tumor cells more sensitive to the 
radiation. This sensitivity allows the radiation to do more damage to the tumor cells. 
Administering the radiation and CT prior to surgery has been shown to improve the 
effectiveness of the surgical treatment and, also, to decrease the risk of side effects [32]. 
 
 
2.5.3 - CHEMOTHERAPY 
 
CT is one of the most used treatments against cancer and it’s through drugs 
administration. Indeed, over the years, the development and use of chemotherapy have 
resulted in the successful treatment of many people with cancer. The ability of CT to kill 
cancer cells depends on its ability to halt mitosis. Usually, chemotherapy drugs work by 
damaging the RNA or DNA that instructs cells on how to copy themselves in division. If cells 
are unable to divide, they die (apoptosis). The faster that cells divide, the more likely CT is 
to kill the cells, causing the tumor to shrink. 
 CT is called a systemic treatment because it affects the entire body.  
CT drugs that affect cells only when they are dividing are called cell-cycle specific. 
Chemotherapy drugs that affect cells at rest are called cell-cycle nonspecific. The 
therapeutic modalities available for the treatment of CRC include CT and can be 
administered in two ways: systemic chemotherapy (intravenous or oral administration with 
achievement in all areas of the body) and regional chemotherapy (administration artery to 
a particular body area). CT may also be used at different times after surgery - adjuvant 
chemotherapy - with a preventive aim of recurrence and tumor prior to surgery with the aim 
to reduce the tumor - neoadjuvant chemotherapy [39, 45- 47]. 
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In advanced cancers, CT can also be used to help reduce tumours and relieve 
symptoms for cancers that have spread to other organs, such as the liver. 
Agents and / or chemotherapy regimens more used in the treatment of CRC are: 
Xelox (capecitabine plus oxaliplatin), Folfox (5- fluorouracil (5-FU), leucovorin (LV), 
oxaliplatin) and Folfiri (5-FU, LV, irinotecan) [39 and 45- 47]. 
 
Type of Agent Mechanism Examples 
Alkylanting 
Modification of nucleic acid 
functional groups 
Cyclophosphamide, 
dacarbazine  
Antimetabolites 
Nucleoside analogs, alters 
RNA and DNA synthesis  
5-FU, gemcitabine  
Taxanes 
Disruption of microtubule 
formation, blocks cell division  
Paclitaxel, Docetaxel  
Anthracyclines 
Interfere with DNA replication 
process, inhibit RNA and DNA 
synthesis  
Doxorubicin  
Platinum based 
Cross link DNA  Cisplatin,  carboplatin, 
oxaliplatin  
 
Table 5. Common types of chemotherapy agents and their mechanisms. 
 
 
The main agent is 5- fluorouracil (5-FU), an inhibitor of Timidilato synthase [38-39]. 
The 5-FU is commonly administered with Leucovorin (LV), which increases the affinity of 
agent for the therapeutic target [39-40]. There is evidence that when compared to separate 
administration 5-FU, the combination 5-FU and LV increases the therapeutic response. 
Among patients with metastatic CRC in about 20% register to a 50% reduction in tumor 
size, with increased survival of 6 to 12 months [39]. The 5-FU is usually administered 
intravenously with the infusion better tolerated than bolus with a lower incidence of side 
effects such as diarrhea and neutropenia [48].  
In order to improve the outcome of selected patients with metastatic CRC, 
monoclonal antibodies against VEGF and against epidermal growth factor receptor (EGFR) 
should be considered in combination with chemotherapy. Bevacizumab, an anti-VEGF 
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antibody, increases the activity of an active cytotoxic regimen, therefore, increases the 
survival, progression-free survival and response rate in first-line treatments. 
Nowadays, several approaches are being studied to improve the activity and to 
reduce the side effects of chemotherapy. 
The side effects of chemotherapy depend on the type and dose of drugs given and 
the length of time they are taken. Common side effects drugs can include: 
 Alopecia – although reversible and not endanger to patients’ lives, is seen as one 
of the most stressful secondary effects interfering with patient`s body image; 
 Gastrointestinal system symptoms – anorexia, nausea, vomiting, mucositis, 
stomatitis, diarrhoea, taste changes, smell of food aversion;  
 Neuropathies; 
 Skin colour changes; 
 Decreased libido; 
 Fatigue, tiredness. 
  Data from: National Cancer Institute, 2011 [74]. 
 
Radiation side effects are usually mild and reversible, and include local changes in 
skin, fatigue, pain related to temporarily inflammation of the nerves or muscles in radiation 
domain [74]. Chemotherapy because induce local and systemic immunosuppression affects 
adversely the training, recruitment and action of effector cells of the immune system and 
that can cause more side effects and precipitating a treatment failure [49].  
 
 
2.6 -  PROGNOSIS 
 
The stage of disease at diagnosis is a determinant factor in survival of these patients. 
As most recurrences occur in first four years post surgery, the survival rate at five years is 
a good indicator of healing [40].The analysis of survival rates at 5 years of CRC shows that 
when the diagnosis is made early, survival is larger, decreasing while the stage progresses. 
For stage I, the survival exceeds 90%, falling to 70-85% in stage II to 25-80% in stage III 
and less than 10% in IV [40]. On average, survival rate after the detection of metastatic 
disease has risen from 6 to 9 months to around 24 to 30 months [40]. 
Although the clinical and pathological staging be fundamental, the preoperative 
dosing of carcinoembryonic antigen (CEA) is also very important, since it may indicate the 
risk of recurrence of cancer. Unlike other tumors, primary tumor size, nodal adjusted to 
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achievement and the degree of differentiation, not directly associated with the prognosis of 
the patient [40]. 
 
 
2.7- ROLE OF NK CELLS IN CRC 
 
NK cells are believed to play an essential role in the immune surveillance against 
tumors and infectious diseases.  
In accordance with some investigation studies that analysed the number and activity 
of NK cells in patients with colon cancer, lead to the suggestion that reduced NK cell activity 
is associated with metastatic tumour growth in patients with colon carcinoma; and, if the 
decreased NK cell activity precedes the development of metastasis, it could constitute a 
possible a marker to identify a high risk of rapid tumour progression following curative 
colorectal surgery [50]. 
According to Halama et al [51], the early impairment of NK cells is decisive for CRC; 
the same is not true for other immune cells, especially for T cells which don’t have a so 
uniform presence during the different stages of CRC. Furthermore, they indicate a pivotal 
role for an escape from NK cells for CRC tumourigenesis and propose that quantification of 
NK cells within CRC tissue can be used as an important parameter for the detection of 
response therapy. 
 
 
2.8 - FOLLOW-UP 
 
The main objectives of the follow-up of patients with a history of CRC are the 
diagnosis of metachronous polyps or new primary CRC and the detection of recurrence 
(liver, lung) at an early stage, in which may also be candidates for a curative treatment, like 
what happens with liver metastases, which may undergo surgical resection [38]. 
Therefore, the follow-up of these patients may improve their survival rate and 
includes periodic medical evaluations and conduct many additional complementary exams 
of diagnosis [34]. 
Current guidelines from the American Society of Oncology Clinical , in relation to 
survival rate after curative treatment of CRC, reflect a change of attitude towards the role 
of TC performed routinely [15]. 
 A colonoscopy reassessment is indicated 3 years after surgical treatment, and if 
negative, every 5 years [52]. Flexible sigmoidoscopy is recommended every six months for 
5 years for patients with rectal cancer who haven’t submitted to radiotherapy [52]. 
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Although it continues to be one of the most common cancer in the last decades, 
deaths from CRC have been declining, in part very due to an effective screening and follow-
up program as well as a more effective diagnosis. 
 
 
2.9 - QUALITY OF LIFE  
 
In recent years, an increasing awareness of interpersonal and emotional 
repercussions of cancer and its treatments has happened, as well as its impact on the 
welfare of patients. Thus, the attention has been directed also to the psychosocial needs of 
patients, their families and health professionals and to the impact of emotional and 
behavioural factors at the beginning and during the course of the disease.  
The diagnosis of cancer is a major source of anxiety, depression and emotional 
stress which affects the quality of life of patients. Approximately 20-40% of cancer patients 
exhibit significant levels of depression and anxiety [77].  
WHO defines QOL as an individual's perception compared to their position in life, 
the values and cultural context and in which the individual lives and their relationship with 
their objectives, expectations and concerns. This is a comprehensive concept of a complex 
affected by physical health, psychological state of the individual mode as well as its level of 
independence, and how their social environment relations, as well as by personal beliefs. 
The concept of quality of life and so the way to deal with cancer is also unique, personal 
and specific to each patient. 
According Psychoneuroimmunology, psychological and emotional stress induce 
severe alterations in several biological responses. Activation of the hypothalamus-pituitary-
adrenal axis and the sympathetic nervous system appears to alter the cells of the immune 
system - reducing the number of NK cells and promote inflammation via multiple 
neuroendocrine and immune pathways. 
According to an adaptation study of the satisfaction scale with social support to 
people with cancer illness diagnosis found that, the satisfaction with the social support 
relates to the all adaptation process to oncologic disease and results, specifically 
concerning to quality of life [53]. Based on the WHO definition of health as “a state of 
complete physical, mental and social welfare and not merely the absence of disease”, it 
becomes essential to see the patient as a whole, recognizing its needs in several aspects.  
The ongoing research in such an important area as cancer is undoubtedly essential. 
More and more is known about its causes, risk factors and development. New ways to 
prevent, detect and treat are also being studied always focusing on improve the quality of 
life of patients with cancer. 
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2.10 - NOVEL APPROACH IN CANCER 
 
A variety of modalities can be used to improve the treatment of cancer patients. A 
combination of those modalities of pharmacological and non pharmacological treatment of 
cancer is a mainstay of supportive care to those patients as presented on the current WHO 
guidelines.  
The study and interest in learning/understanding treatment modalities called 
complementary or integrative medicine has grown significantly in recent years. Highlights, 
the importance of therapeutic relationships between doctor and patient, focus on the whole 
person, including all aspects of life. The central focus is the patient’s perspective, generating 
new strategies and multiplying treatment possibilities. According to Cassileth (2004), cancer 
patients usually use complementary therapies, being that about 91% of these patients used 
some form of complementary therapy during conventional medical treatment, in the United 
States [76]. Although some are expecting these therapies to have an effect on their survival 
time, it seems that most use these methods to improve quality of life. 
One of the so called complementary therapies is the Traditional Chinese Medicine 
that it will discuss bellow. 
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3. TRADITIONAL CHINESE MEDICINE – OVERVIEW 
 
Traditional Chinese Medicine (TCM) is a broad range of medicine practices sharing 
common concepts which have been developed in China and are based on a tradition of 
more 5000 years, including various forms of herbal medicine, acupuncture, massage (Tui 
na) exercise (Qigong) and dietary therapy. 
The oldest findings known, where references to the most primary forms of care are 
shown, are the I Ging (The book of changes) and the Huangdi Neijing (Principles of Interne 
Medicine of the Yellow Emperor) [75]. It is thought that the book Huangdi Neijing was written 
somewhere in between the 2th century BC and the 2th century AC and establish, for the 
first time on the Chinese Medicine practice, some of therapeutic principles of treatment. 
Many of Chinese scientific principles, since Classical China teachings and before 
the Yellow Emperor’s Classic of Internal Medicine, emphasized the regulatory fluctuations 
through circulatory functions in a simplistic manner that is similar to a sinus wave and is part 
of the so-called monad (Leibniz) or Taiji sign. 
Over the centuries, many compilations and reassessments of the whole field of 
knowledge of Chinese Medicine appeared. However, it was on the 16th and 17th centuries 
that the preservation and dissemination of this whole field of knowledge reached its 
pinnacle, with publications such as Zhengjiu Dacheng (Great Compendium of Acupuncture 
and Moxibustion). In it was the theory behind all Chinese Medicine, such as stimulation of 
points and channels, which have been presented so clearly that remain current until present 
day. 
Accordingly to Hempen, it was Soulie de Morant, at France, after 30 years of study 
in China that contributed, in a fundamental way, to provide the theoretical basis for the 
diagnosis and the introduction of Chinese Medicine in the western world [54]. 
Western medicine, as well as any other type of corpus medicus, presents limitations 
both in diagnosis as in interventions. Indeed, for a long time, Western medicine has been 
systematically built and developed based on scientific methodology and, as a result, on the 
possibility of the phenomena being measured.  
Chinese Medicine emerges as another medical approach, considering the human 
being part of a whole, being interested primarily in the expression of life, emotions and vital 
body functions in order to identify possible disharmony. The basic aim is not to measure or 
assess a specific organic change but to evaluate the condition of a patient, reporting 
objective and subjective their symptoms or discomforts. 
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Currently, there is a form of modern understanding of TCM considered crucial for 
their integration into the Western health system and in research. The Heidelberg model fits 
in this context. 
 
 
3.1 - HEIDELBERG MODEL OF CHINESE MEDICINE 
 
TCM is understood as “a system of sensations and clinical signs and findings 
designed to define the regulatory state of the body [55]. 
The Heidelberg Model of TCM developed by Prof. Johannes Greten was supported 
by the pioneering works of the medical-sinologist Prof. Manfred Porket (1974), thus 
adopting a Latin terminology, and also sustained by the Leibniz’ analysis of the I Ging (“The 
Book of Changes”). 
The Heidelberg model is a scientific model that allows a rational access to Chinese 
medicine and it is based on symptoms that constitute the evidence of disease and 
pathological changes.  
It is supported by a system that describes functional abnormalities through its signs 
and symptoms. Thus, it is understood that those signs and symptoms, as well as the feeling 
that the patient describes, are the result of dysfunctions in the body, particularly in the 
neurovegetative system. 
This model of Heidelberg provides an overview of some TCM concepts by 
translating them as states of neurovegetative functions, being crucial to the integration of 
TCM in the Middle West, particularly to what regards the health system. 
On the following picture it is possible to make a western physiological description of 
such neurovegetative functions. 
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Fig 6. Western physiological description of a vegetative sinus wave  
Data from Greten 2010 [56]. 
 
The sinus wave symbolizes a sinus curve of regulation, a circular movement, as the 
classic circle of Yin/Yang, were are described the regulatory model of the phases (Wood, 
Fire, Metal and Water).  
The upper part of the figure contains the Chinese way of description; the functional 
figures symbolize the clinical appearance of the mechanisms in terms of visible signs, the 
lower part contains the wertern description, as transmitters and neural concert of the 
vegetative system [56]. 
For instance, according to Greten (2010), stress is believed to be accompanied by 
a strong uprising sympathetic action, analogous to Wood [55]. At the same time, according 
to western medicine, vagal impulses act to counter-balance this sympathetic action and 
effect. In Chinese terms this is as imbalance of a vegetative functional tendency. The 
functional tendency, called Wood, is more or less analogous to stress and sympathetic 
action, adrenaline increase, muscle tension, and others. In other words, the description by 
groups of clinical signs in the upper part of the figure, describes the same function the 
western medicine describes as a transmitter and neuronal concert of vegetative system. 
As a scientific medical diagnosis, besides the interpretation of symptoms, amounts 
to a second level of abstraction, which identifies causes and agents that can induced those 
changes or dysfunctions [55]. 
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This referred state of dysfunctions can be treated in various forms. The therapy 
includes therefore reflex action at central and vegetative nervous system such as 
acupuncture and manual therapy (Tuina), as well as exercises that activate the vegetative 
system of biofeedback, the Qigong. Herbal and dietetic are also included as an effective 
therapy through the administration of plants, minerals and other products, but also through 
the food itself. 
Chinese doctors look for the all active expressions of life which are seen as 
expression of a balance of energies that flow in a cyclic sequence along clearly defined 
conduits. Therefore, Chinese medicine models is the concepts of functional systems, which 
are establish through a systematic arrangement of its observations, representing the 
symptoms of disorder, different manifestations of vital forces and various phenomena of life. 
 
 
3.2 - DIAGNOSIS ACCORDING TO THE HEIDELBERG MODEL OF TCM 
 
The Diagnosis is one of the most important elements in TCM.  Based on Heidelberg 
Model functional diagnosis is composed of four main steps:  
 
 The constitution: individual functional properties and the inner nature of the patient, 
while agent is regarded as a functional power that may change the individual 
functional properties; it produces clinical signs or induce a group of diagnostically 
relevant signs called orb ; 
 The agent (pathogenic factor): is considered as a functional power or a “vector” that 
have the capacity to change the individual functional properties, producing clinical 
signs;  
 The “orb”, are group of diagnostically relevant signs that indicate the functional state 
of a body island, which correlates with the functional properties of a conduit1; 
 The guiding criteria, , can be understood as the teaching of body regulation. As 
previously described, is regarded as directional standard conventions of physiology, 
permit the interpretation of the actual symptoms that are a manifestation of the 
overall body regulation as described following. 
 
                                                 
1 Conduits refer to a connection of a group of points with effect on the clinical signs of na orb, believed to serve as a conduit for the flow of qi 
and xue.   
EFFECT OF QIGONG IN NATURAL KILLER CELLS ON COLO-RECTAL CANCER PATIENTS UNDERGOING FOR 
CHEMOTHERAPY 
 
 
46 
 
 
Fig 7.  Four components of the functional diagnosis in TCM  
Data from Greten (2010) [55] 
 
According to Greten, the guiding-criteria is an evaluation of clinical signs according 
to an underlying regulatory model of physiology and permit the interpretation of the actual 
symptoms that are a manifestation of the overall body regulation. 
 
 
3.3 - THE ALGOR LAEDENS THEORY – ALT 
 
Refering the ALT in this study becomes crucial because the topics related to cancer 
and chemotherapy are considered according to the Heidelberg model factors that lead to 
the existence of Algor in the body. Algor means the symptoms that you would experience 
as if you were exposed to cold. In case of CT is toxic algor that is a local toxic damage 
following extremely cold substances. That cause a process that we called ALT. The ALT is 
the most common pathophysiological model that describes the process of “cold-invading” 
diseases in TCM, which have a parallel on clinical signs induced by neuroimmunological 
mechanisms on a western perspective. The ALT assumes that in case of “algor” affecting 
the body system, a regional lack of microcirculation may be caused by defence reflexes to 
cold, by viruses (adhesion molecules, complement system, coagulation) in face of which 
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and a counter-reaction(“reactive calor”) take place, consisting on a general increase in 
microcirculation, inflammation, fever and sepsis.  
The model course of the ALT is suggested under the basic idea that the agent 
invades from the extima to the intima, thereby overcoming the defence levels and revolving 
the flow of Qi2 and xue3, and constitute a specific approach of interpretation of the guiding-
criteria extima/intima, as stages I to III are extimal (yang) and stages IV to VI are intimal 
(yin).  
The ALT combines the language of the orbs (neurovegetatively originated signs) 
with the language of the system of calor/algor, a part of neuroimmunology, and reflects the 
functional activity of the defence mechanisms expressed by calor (yang) and algor (yin). 
The six stages of the ALT are syndromes composed of specific signs of two orbs, 
each. According to the model, the six stages form a complete circle of stages of an infectious 
disease. During the course of such cyclic process, an individual will overcome the infection 
and remain healthy thereafter. However, under certain circumstances, some signs of the 
six stages may remain and become chronic, such as in cases of chronic inflammation, 
fibromyalgia or rheumatic disorders. 
 
 
 
 
 
 
                                                 
2 Qi refers to vegetative capacity to function of a tissue or organ which may cause the sensation of pressure, tearing or flow.   
3 Xue refers to a form of functional capacity bound to body fluids with functions such as warming, moisturizing, creating qi 
and nutrifying a tissue.   
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Fig 8. The six layers of energy. 
Data from Greten( 2010) [55]. 
 
Stage I – Agent overcomes the defensive Qi- Yang major 
When the agent algor invades the skin, it affects the defensive Qi. This may induce 
a localized de-activation of xue, in western terms regional lack of microcirculation. Yang 
stands for extima, for activity in general and within the meaning of the phases it stands for 
reactive calor ( stage I, II, III). 
 
Stage II – Agent blocks the flow within the conduit- Splendor Yang 
Splendor Yang, the overshining yang, express that reactive calor may even be 
excessive and symptomatically leading. By this it is expressed that in western medicine 
sence the reaction to the agent algor or a virus produce more symptoms than the virus itself. 
If expelling of algor fails, it may proceed invading and lead to a regional block of flow of Qi 
and xue that causing pain.  
 
Stage III- Agent and Qi flow in the conduit compete- Yang minor 
This express that the reactive calor (yang)is regressive so the agent is bigger and 
the yang is minor. Xue and Qi derive from the interior and are led through the system of 
conduits.If agent algor overcomes the xue flow this may lead to a reverse flow of xue into 
interior. 
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Stage IV- Agent interacts with Qi of the body island- Yin major 
The agent algor invade the interior – zone of lack of microcirculation. Algor is in the 
body. The main symptoms do not come from the conduits but more frequently from the 
interior. The most pronounced lack of function seen on the Stage V, where the substance 
is used up, is called in Chinese Jue yin and in Latin Yin flectens meaning that the yin “goes 
away”, vanishes, but also bends. It represents a turning point of the disease when it 
becomes life-threatening, dangerous and critical. 
The other two stages are, again, named in a comparative manner in relation to the 
acute Stage V. Thus, the Stage IV, where there is more substance blocked, more yin is 
called the bigger yin, Taiyin, yin major; and the stage where there is less substance left, the 
yin is smaller is named the smaller yin, Shaoyin, Yin minor – Satge VI. Another major aspect 
of these two Stages (IV and VI) is that the bigger yin has a downward direction, meaning 
that the hypofunctional state of internal algor is becoming more pronounced, “more yin” or 
yin major; in Stage VI the hypofunctional yin state have a upward direction comparable to 
the phase of water (regeneration) in the model of phases, having the capacity to regenerate 
to normal, is called lesser yin or yin minor 
 
 
Fig. 9. Schematic model of Algor Laedens Theory. 
Data from Greten (2010) [55]. 
 
Therefore, these six functional layers are also called the six layers of defence the 
body. The extimal stages of defence encompass the defensive Qi as first layer, followed by 
the Qi of the conduits and, finally, the xue of the conduits; and the intimal stages includes 
the Qi of the body island, followed by the xue of the body island and finally the yin [55]. 
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The energy layers comprise six technically different forms of energy:  
I. Defensive Qi, also referred as wei Qi, resides within the extima, outside the 
conduits and builds up the first barrier against external attacks.  
II. Conduit Qi is the Qi within the conduits. When this second layer of defence is 
affected by an agent causes a block in the flow of Qi resulting primarily in pain and 
secondarily in functional disorders of the respective orb.  
III. Conduit xue, which is driven by the conduit Qi and warms the conduits, 
“nourishes” and “moisturizes” the tissues. The warming effect on the tissue is needed e.g. 
to drive out the agent algor.  
IV. Body island Qi is the Qi within the intima, a general name for the whole body’s 
interior, where the functions of the orbs are generated in their respective parts of the body.  
V. Body island xue, is a substancial (yin) part of the body islands with warming, 
thus functionally activating and enhancing properties.  
VI. Yin, which is the functional tissue the respective subpopulation 
 
Therefore, it’s possible to distinguish six strategic scenarios in which the agent 
attempt to overcome each functional layer producing symptoms related to the invading 
agent (feeling of coldness) and symptoms that arise from the interaction of the agent with 
the layer of defence, which are specific key symptoms, thus enhancing diagnosis of the six 
layer model. 
 
 
3.4 - CANCER ACCORDING TO TCM 
 
From a Traditional Chinese Medical perspective, all cancers are considered different 
manifestations of constrained Liver Qi. Because the Qi commands the Blood and keeps it 
moving in its proper pathways, any disorder in the Qi will lead to a disorder in the Blood. As 
the circulation slows down, the Blood begins to congeal and becomes stagnant. This 
comprises the first stage in the potential development of a cancerous tumor [56]. 
Traditional Chinese Medicine stresses that cancer formation is caused primarily from 
a deficient condition (whole body weakness), which can then develop into a localized 
excess condition (the specific cancer tissue formation). The acquired excess condition can 
also enhance the development of a systemic deficiency (the deterioration of the entire 
body), as well as destroy the entire body's immune system. 
According to TCM, deficient Spleen, Lungs and Kidney Qi is also considered a 
contributing factor in the development of cancer. These specific internal organs are directly 
involved in stimulating and nourishing the body's True Qi, Righteous Qi, Ying Qi, and Wei 
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Qi. Deficient Qi in the Spleen, Lungs, and/or Kidneys depletes the body's natural defenses, 
making it easier for diseases of all types, including cancer, to take root and thrive [56]. 
According to Jerry Johnson (2002), the etiologies of tumors and cancers are 
considered multifaceted in their disease formation. They are generally viewed as being 
created and formed through a constant attack and weakening of the tissues, originating 
from imbalances in one or more of the five following factors:  Environmental Factors, 
Chemical Factors, Physical Factors, Psychological Factors, and Energetic and Biological 
Factors as described the figure below  [56]. 
Environmental Pathogenic Factors also include exposure to radiation, ultraviolet 
rays, industrial toxins and the six pathogenic factors (Wind, Cold, Summer Heat, Dampness, 
Dry-Heat, and Fire). Chemical poisoning linked to cancer formation can take place through 
exposure to pesticides, herbicides, growth hormones in meat and dairy products, genetically 
altered foods and others. A congenital tendency towards specific types of tumors and 
cancers (inherited weakness), involves the inability to repair weakened DNA. This leads to 
uncontrolled cellular replication, and hormonal imbalances. Emotional stress can originate 
from an inability to handle intense emotional states, causing the individual to suppress his 
emotions and resulting in chronic organ disharmony. Once the harmony of the body's Qi, 
Blood, Body Fluid, internal viscera, and channel circulation is disrupted, the immune system 
becomes overworked, which lowers the body's resistance to disease. 
 
Fig. 10. The causes of tumor and cancer formation according to TCM. 
Extrated from Jerry Johnson (2002) [56]. 
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3.5 - CANCER ACCORDING TO THE HEIDELBERG MODEL OF TCM 
 
Cancer, accordingly to the Heidelberg model, is understood in a comprehensive 
manner, as the result of a disharmony between Qi defensivum and Qi construtivum. 
In conventional Western medicine, cancer is considered a process in which 
malignant cells outgrow environmental constraints and control mechanisms. In TCM 
overview, cancer results from a disturbance of smooth flow of ‘Qi’ (vital energy) and/or 
yin-yang balance and manifests as a group of syndromes in which there is a disharmony in 
the body–mind–environment network. In a very general way, what happens is that the 
referred disharmony causes, over time, a Qi and blood (xue) stagnation, which can lead to 
blockage states and accumulations. 
According to Heidelberg model, the causal therapy for cancer is to eliminate stasis 
of xue. The cause of stasis must be diagnosed individually. Numerous disturbance and 
blocks may contribute to this, such as old trauma, chronic algor and other blocks of the 
conduits. Patients who don’t have much Qi and consequently not much flow of xue are 
prone to stases.  
Specifically, by local findings, this stagnation may result in three principal stages: 
 Stage I – consists of local accumulation of humour and pituita (similar to edema in 
western medicine) that causes or makes the conduits obstruction becomes worse 
resulting in more xue stasis.  
 Stage II – Named congelatio, situation in which an excess of a palpable substance 
still moves in the tissues, it can resemble a situation of existence of cysts or chronic 
exudates.  
 Stage III – Named concretio, which is a local accumulation that is not mobile; These 
benign tumours may indicate that the tendency of block of Qi flow, block of xue flow 
and excessive constructive Qi is already present although the patient has no cancer. 
This is treated as benign or malignant, situations such as lipomas, fibromas or other 
neoplasic conditions. 
 
The concept here involved is that the defensive Qi tend to disperse the accumulation 
of constructive Qi and, when this process fails, pathological situations arise [55]. So we can 
conclude that cancer may result from an imbalance on the Metal-Wood axis. These 
represents an imbalance of Qi defensivum and Qi construtivum, where Qi defensivum can 
be understood as a vegetative defence mechanism originated in the respective tissue itself 
and promoted by the continuous action of inspiration and expiration, as well as the 
vegetative rhythm induced by that; and Qi construtivum is derived from xue, which 
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corresponds to the western term of microcirculation (MC). This is analogous to the concept 
that growth factors, hormones and other factors, which will normally contribute to tissue 
repair, would reside in the respective tissue as a result of impaired flow of MC, possibly 
induced, as among other factors, by a lack of capillary outflow. From a western perspective, 
this is to be regarded as a vegetative theory of carcinogenesis. This implies, also, the 
inclusion of emotional changes and psychosocial causes of cancer by Chinese medicine.  
On another point of view, according to Heidelberg model, the Chinese 
psychosomatic theory of the origin of cancer lead to conclude that cancer is a disease of 
disturbed symbiosis and partnership. On other words, is an imbalance between maeror and 
ira or symbiosis versus autonomy. Similarly, according to the western theory, cancer can 
be induced from life significant events that lead to emotional significant disturbances. This 
is consistent with western science which tries to catch this in the term of life-event research. 
In western research, the intact social and family structures prolong the life of cancer patients 
and positive attitudes to fighting against cancer also prolongs survival [56]. 
 
 
3.6 - CHEMOTERAPHY ACCORDING TO THE HEIDELBERG MODEL OF TCM 
 
Chemotherapeutic agents, as previously mentionated, are considered as a form of 
algor, toxic algor, which leads to the occurrence of symptoms of coldness, tiredness and 
stiff limbs, and, therefore can be interpreted by the ALT.  
Chemotherapy induces cold directly and may affect all the six levels of Qi in the ALT 
and the symptoms presented by the patient differs according to the stage of invasion.  
On Stage I, the wei Qi is deficient, the most common algor-related signs are 
shivering and painful limbs. On Stage II, patient reveals severe and tearing pain in different 
regions of the body, loss of appetite, nausea and extreme sensitivity to smell. As on this 
stage, the algor affects the Stomach orb and patient develops a splendour yang syndrome 
with accumulation of pituita 4, which affects the face becoming swollen. Also affects the 
crass intestinal, appearing gradual diarrhoea and pain in the abdomen. On Stage III, 
appears on the beginning of the chemotherapy, where the xue of the conduits is affected, 
and giving rise to the alternating sensations of hot/cold. In the Stage IV toxic algor can affect 
the Qi of P5 and L6 orbs and leads to more vulnerability to airways infections and feelings 
                                                 
4 Pituita, according to Heidelberg model, refers to accumulation of humor and reactive calor during time. In western terms 
refers to chronic inflammation signs that may originate from pre-oedema and oedema.   
5 Pulmunar 
6 Lienal 
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of dullness respectively. In Stage V, the xue of H7 and PC 8body islands is affected, thus 
the muscles become inactive (weakness of arms and legs) and also may give rise to 
palpitations, loss of drive and weakness due to the presence of toxic algor in the pericardium 
or heart muscles. The extreme yin deficiency (cachexia) is due to tumour itself, but also 
enhanced by chemotherapy; affection of structure and function; affections of the urinary 
tract and affection of the brain, more precisely short-memory loss - Stage VI. 
 
 
3.7 – QIGONG 
 
Qigong is not intended to replace orthodox medicine, but rather to complement it. 
Qigong is one of therapy of TCM; the word is composed of two Chinese characters, Qi and 
Gong. Qi is often translated as energy and Gong as work, so to describe that it means the 
work on energy. It is an ancient Chinese art and science working true posture, movement, 
breathing and meditation. 
 
 
3.7.1 - OVERVIEW OF QIGONG 
 
More than 5000 years ago, Chinese physicians came to understand that everything 
is composed of the same energetic substance called Qi. These ancient masters concluded 
that energetically everything is interconnected as one body, although energy may appear 
to take on many different forms. In modern times, the laws of physics have demonstrated 
that matter and energy are interchangeable, and that matter is simply another form of 
energy [56].  
Once we understand the meaning of Qi, we could understand the medical capacity 
of Qigong. 
As a biofeedback therapy, Qigong activate psychophysiological self-regulation to 
restore or maintain a healthy balance overall [55]. Those exercises can be done sitting, 
standing, moving or lying down.  
According to Pedreros (1992), Qigong is a set of internal exercises to cultivate the 
Three Treasures, which are the hallmarks of mental and physical health of human beings. 
In China, health and longevity are determined by the strength, balance and cultivation of 
                                                 
7 Hepatic 
8 Pericardiac 
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those three treasures called: Jing, Qi and Shen, representing the human being holistically 
[57]. 
According to the same author, regular practice of Qigong activates the internal Qi 
flow along the conduits, strengthens internal organs, maintains the vigour of body and mind, 
exercises the joints, muscles and tendons, prevent diseases caused by physical stress and 
promotes postural awareness.  
There are hundreds of different forms of Qigong in China and, most of them are not 
intended to treat any specific disease but are used almost as prophylactic meditative 
exercises. Dispite this, all share the same core principles:  
 regulation of the body - the body is held in a stationary position or executes 
a series of specific movements;  
 Calm the mind - the mind is cleared of all elements of distraction and 
focused on a single thought or meditative visualization of "Qi" to circulate 
through the body;  
 The "Qi" can be understood as life energy and according to some authors, 
is considered a dynamic and ethereal with potential energy and feedback 
information.  
 Qigong is a practice of training that leads to the development and control 
of "Qi" and its distribution across different parts of the body. It is considered 
a traditional therapy that integrates bio vegetative feedback postural, 
breathing, movement and meditation exercises with stabilizing properties 
vegetative and aimed at self-regulation of body biological systems (...). " 
 
Qigong is, according to the model Heidelberg, a traditional therapy of vegetative 
biofeedback that integrates postures, breathing, movement and meditation exercises with 
stabilizing properties vegetative and aimed at self-regulation of the body systems [55]. This 
is because stimulation of autonomic reflex points, which are connected to each other 
through interconnection by collagen (conduits) fibers, stretch and relax is a systematic 
manner [56].  
Qigong is considered a method of self practice or process by which one cultivates 
the Qi and Yi (consciousness or intention) with the aim of achieving an optimal state of 
health of body and mind [57]. 
For this reason, Qigong has the functions of activating the body´s vital force (Qi), 
strengthening the blood´s circulation, balancing yin and yang, stimulating the conduits and 
improvement psychological state [59]. In TCM the psychological capacity is a function of 
Shen. Shen is a functional capacity to put order into mental associativity and emotion, thus 
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creating “mental presence” [55]. Porkert defines shen as a constellating force which 
originates from cardiac orb [60]. 
In the early 1950s scientists in China began investigating the many medical benefits 
claimed for Qigong. Clinical and experimental evidence shows that Qigong exercise can 
affect various functions and organs of the body. Several studies have emerged to realize 
the effectiveness of Qigong in various medical aspects. I will discuss later the extent of 
research on Qigong and cancer. 
 
 
3.7.2 – THE ROLE OF QIGONG IN CANCER 
 
In the last years, in the field of modern medicine, comes an approach for treatment 
of cancer that considerer the condition of whole person as the environment for the cancer 
and to strengthen the body`s resistance to cancer. Relies on many factors such as, 
exercise, diet and meditative states, Qigong is part of this approach. 
Accordingly to Sancier (1999) in a review of clinical studies on the therapeutic role 
of Qigong exercises done in conjunction with drug treatment in cancer patients, Qigong is 
able to reduce chemotherapy side effects [61]. 
It is known that Qigong can produce an increase in the absorption of oxygen through 
the postures, movements and breathing. A crucial explanation pointed by Dong’s(1990), is 
that one of the important factors in cancer growth or not is the body´s content of oxygen. 
So if we have sufficient amount of oxygen cancer cells may die, and otherwise when the 
body is deficient in oxygen, cancer cells grow.  
Accordingly to Chen (2002), Qigong maybe a beneficial option for cancer patients 
and a possible mechanism of interest in cancer reviews [58]. This author did a literature 
review of more than 50 studies of Qigong therapy in cancer treatment in China by dividing 
them into three categories: clinical studies with cancer patients, in vitro studies with cancer 
cells and further studies in live animals affected with cancer. Clinical studies involving 
observation of cancer patients who practiced Qigong. From the review, they found that there 
is a consistent trend for the groups who practiced Qigong in combination with conventional 
treatments had significant improvements and increased average life expectancy compared 
to those groups treated only with conventional treatments. 
According to the same author, Qigong produce an improvement of the immune 
function, which may enhance the immune deficiency experienced by most of cancer 
patients and the improve of the  microcirculatory function including changes in blood 
viscosity, elasticity as well as platelet functions. It is stated that through Qigong therapy it 
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can be adjust the microcirculation to a state considered optimal increasing the effectiveness 
of certain treatments, such as CT.  
As concluded by Sun and Zhao, in a clinical study on several advanced cancers, 
Qigong is able to improve strength (82%), appetite (63%), as well as to reduce 
gastrointestinal symptoms (33%). Moreover, these authors found that the Qigong was 
responsible for increasing phagocytic rate of macrophages as well as the phagocytic index 
[62]. 
Another study from Shanghai Fangyi Hospital, reported changes in the immune 
indicators and physical health among 1,883 cancer patients after practicing Qigong. After 
practicing Qigong for 2 months, they reported that most patients showed remarkable 
improvements on white blood cells, CD20, IL-2 and NK activities. In addition, 40.8% patients 
reported improvement in sleep, and 36.8% reported improvement in appetite. This strongly 
suggests that the effect of Qigong therapy for cancer is not purely psychological [63]. 
Many studies show that the increase of NK cells and many other components of the 
immune system can significantly reduce the chances of infection or tumor growth [64-65]. 
Given the fact that most cancer therapies tend to damage or destroy patient’s 
immune functions, which reduce the patient’s overall capability of self-recovery, the 
indication of improvement in the immune system from Qigong therapy warrants further in-
depth research of its therapeutic effect on cancer. 
In conclusion, therapy through Qigong can be a valuable and indispensable in the 
treatment of patients with cancer, complementing conventional treatments. 
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 II - CLINICAL RESEARCH PROTOCOL 
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1. OBJECTIVES  
 
The objectives of this study are: 
 
1) Evaluate the effect of Qigong on NK cells.  
1.1 Question 1: Will Qigong exercise practice a positive influence on the number of 
NK cells, T and B lymphocytes in patients with CRC under chemotherapy?  
 
2) Evaluate the effect of Qigong on anxiety and depression  
2.1 Question 2: Does Qigong improve levels of anxiety and depression in patients 
with CRC under chemotherapy? 
 
3) Evaluate the effect of Qigong on quality of life of patients  
3.1 Question 3: Does the practice of Qigong improve QOL of these patients?  
 
4) To correlate the effect of Qigong on NK cells with quality of life as well as 
the levels of anxiety and depression in patients with CRC.  
 
4.1 Question 4: There will be a positive correlation between the immune 
parameters and the QOL, levels of anxiety and depression of these patients? 
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2. METHODOLOGY 
2.1 - SAMPLING AND RECRUITMENT PROCEDURES 
 
2.1.1 - PATIENTS SELECTION 
This study was approved by the ethics commission of Portuguese Oncology Institute 
of Porto (IPO) on July 2014 and will be conducted at the Clinic of Digestive Pathology 
integrated in the IPO Porto. Written informed consent was obtained from all patients before 
study enrollment. Patients were eligible for inclusion as follows:  
 
 
The inclusion criteria:  
 Newly diagnosed or recurrent colorectal cancer, regardless of stage; 
 Receiving myelosuppressive chemotherapy;  
 No regular use of acupuncture or any TCM therapy within 120 days prior to 
enrollment;  
 Ability to give informed consent; 
 Age >18 years of age.  
 
The exclusion criteria: 
 Absolute neutrophil count (ANC) less than 500/μL; 
  Platelet count less than 25,000/μL; 
 Altered mental state; 
 Clinically significant cardiac arrhythmias; 
 Other unstable medical condition. 
 
 
2.1.2 - STUDY DESIGN 
The study was an experimental, prospective, pilot clinical trial, with a randomized 
and controlled design. 
All patients enrolled were evaluated at baseline. Patients were randomized into one 
of two groups: Qigong (Qi group) or non-Qigong (control group). All of the study patients, 
were blinded to randomization assignments. It was used the technique of simple 
randomization sampling: enrolled patients were assigned with consecutive numbers in order 
of recruitment and subsequently allocated as follows: odd numbers was allocated in the 
control group and even numbers in the experimental group. 
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All patients enrolled was evaluated at baseline. Patients was randomized into one 
of two groups: active Qigong group (Qigroup) or non-Qigong group (control group).  
 
2.1.3 - EXPERIMENTAL GROUP 
A session prior for clarification was made. Patients in the experimental group 
received 6 sessions of Qigong therapy, twice a week between the CT protocol. This 
treatment is started at week after the beginning of the cycle of CT and is repeated twice a 
week until the end of the CT regimen (Figure 1).  
The method of Qigong therapy applied was standardized based on the model of 
Heidelberg Traditional Chinese Medicine advocated the teaching area in the Master of MTC 
ICBAS-UP. 
 
2.1.4 - CONTROL GROUP 
The control group consisted of patients with the same pathology and receiving the 
same CT regimen but they just being collecting the blood sampling for the study without 
receiving any Qigong treatment. It was offered to these patients the Qigong therapy protocol 
as a courtesy, immediately after they completed the four weeks of blood sampling. 
 
 
Figure 11. Study flow chart. CBC, complete blood counts; NK, natural killer cells counts; WBC, 
white blood cells; ANC, absolut neutrophil counts. Blue Arrow, Qigong therapy (QG); Black circle 
corresponds to blood collecting samples at baseline (T0). Black diamonds (T1, T2 e T3) 
correspond to each subsequent 7 days blood collecting samples. 
 
3. INTERVENTION 
All patients enrolled were evaluate at baseline. Patients were randomize into one of 
two groups: active Qigong group (Qigroup) or non-Qigong group (control group).  
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3.1 - EXPERIMENTAL GROUP 
A session prior for clarification was made. Patients in the experimental group 
received 6 sessions of Qigong therapy, twice a week between the CT protocol. This 
treatment was started at week after the beginning of the cycle of CT and was repeated twice 
a week until the end of the CT regimen.  
The method of Qigong therapy applied was standardized based on the model of 
Heidelberg Traditional Chinese Medicine advocated the teaching area in the Master of MTC 
ICBAS-UP. 
 
3.2 - CONTROL GROUP 
The control group consist of patients with the same pathology and receiving the 
same CT regimen but they just being collecting the blood sampling for the study without 
receiving any Qigong treatment. At this group we offered the Qigong therapy protocol as a 
courtesy, immediately after they completed the four weeks of blood sampling. 
 
3.3 - QIGONG PROTOCOL INTERVENTION 
The Qigong program runs for 3 weeks with 2 sessions per week of 30 minutes 
(Figure 11). The Qigong intervention program is a traditional Qigong program directed 
specifically to the diagnosis of cancer in specific, to strengthen the immune system; each 
session consisting of various exercises selected for the case.  
The technique applied Qigong, called "Happy Qigong" and consists of the sequence 
of a set of exercises with the aim of promoting feeling relaxation, wellness and relaxation, 
but above all, lead to an acceleration of body energy.  
 
The sequence of exercises begins after all participants are silent in a large room and 
focused on what they are asked to perform. This sequence is developed as follows: 
 
1. Imagining one of the happiest moments in life. Feel this sense of well-being and 
absolute happiness. Concentration eight breaths during that time. 
 
2. "Standing" and "white ball" - duration of 8 breaths. 
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a) Standing - Feel the point Fons Scatens (R1) of the body, located in the middle of 
the foot. 
 
Fig.12- Acupoint R1 ( Fons Scatens) 
Data from  Porket M.,1995 [60]. 
Put your back into a straight position. Set the knees in order to lead to a higher 
concentration to the point and adjust all posture, moving it slightly forward or backward to 
find the balance. 
After, focus attention on the point Conventus Omnium Yang (RG20), located on 
top of the head. 
 
Fig 13. Acupoint Rg 20 (Conventus Omnium Yang) 
Data from Porket M.,1995 [60]. 
 
Feel the extension of this inner shaft toward the center of the earth.  
Make the connection with the two points by adjusting body posture, checking the 
connection RG20 and R1. 
 
b) White ball 
The completion of this exercise is done with eyes closed, putting his arms in front of 
her arch-shaped and set a distance of at least 20cm between both hands. Should relax , 
exhale deeply to improve the flow of Qi. 
Turning point Medium Palmae (PC8) between one hand and the other. Remain in this 
position for 8 breaths . 
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Fig. 14 – Acupoint PC8  ( Medium Palmae) 
Data from Porket M.,1995  [60] 
 
 
3.Awaking the Qi 
Raise your arms slowly in front of you with your arms straight and your palms facing 
down. On the head, stretch your arms, with your palms facing the sky and feel as if the body 
were being pulled by a rope. Feel this stretching the spine. When the arms are outstretched, 
lifting your heels, keeping the body weight supported as much as possible on tiptoe. Holding 
his breath and a quick and invigorating, so back down to keep your feet flat on the floor. 
Exhale and slowly down her arms. Repeating 8 times.  
 
4.Shoulders roll 
This exercise begins with the person standing relaxed position. Qigong position. Curl 
your shoulders slightly, palms start down the lateral aspect of both legs (felleal condui). In 
performs motion inspiration. When you can not extend the movement without having to 
bend your knees, in maximum until 90º. Back up, always with the hands to rise close to the 
body, this time, go up through the palms in front of the legs (stomachal conduit). This 
movement is executed during expiration. 
When the body is practically in the standing position, slightly role your shoulders to keep 
your back straight and place your hands at your sides with the palms of the hands parallel 
to the floor. Inhale and exhale and repeat the exercise again until 8 times.  
 
5. Network 
Standing, legs together and knees slightly bent. Place the hip to one side, the body 
slightly leaning forward and to the opposite side of the hip. The elongate arms forward to 
the opposite side to the hip, or follow the inclination of the side of the body. With hands with 
palms facing up, making a motion as if pulling a rope towards the chest ( cardiac mu point). 
When hands lead to "rope" to the chest, repeat the exercise for the other side, not forgetting 
the always hip to the opposite side arm.  
In the passage from one side to another exercise, the arms remain stretched 
forward, hands with palms facing the floor and the body rotates slowly return to starting 
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position, to start the movement. In this passage, when hands glide in front of him, imagine 
that these slip on fresh water from the sea, but never get to touch this. Imagine the feeling 
of freshness in the hands with this passage. Repeat the exercise until 8 times.  
 
6.Rotate the ball 
Standing in Qigong position. Bent more the knees. Hold the White ball.  
Turning to the body side and the right arms are attached; the right arm is above the left and 
underneath, keeping the arched shape of the arms as if to grab the ball. The feet on the 
ground to rotate the right side as well as the knees. These must be fitted, namely, the left 
knee fits the back of the right knee that rotated forward. The heel of the left knee raises 
slightly putting pressure on his right knee. 
Repeat for the left side. In the passage from one side to the other feet glide on the 
floor and hands are always as if holding a ball. On each side we turn the arm that is on top 
is always the side arm that we are facing. Repeat the exercise 8 times  
 
7.Pump 
Standing with one hand in a fist in front of the chest, close to the ribs. Shoulder 
forward. Always with the hand in the same position, dragging his hand vigorously in the 
body, following the intercostal line to the lumbar region. The body follows the movement 
and will slowly turning. In the lumbar region, always hand in a fist, down vigorously until the 
sacrum, always following the line of the column. Lobby movement feeling the vertebrae in 
its passage. When the hand reaches the sacrum, it starts movement with the opposite hand, 
the chest again and repeating the same cycle. Repeating 8 times to each side.  
 
8.Earthquake 
Stand in Qigong position. This exercise is to run a vibration throughout the body and 
adapted and tailored to each, according to what is comfortable for each person. Allowing 
the whole body to perform a continuous mixing in the form of a frequency continues. Keep 
focused attention during the execution of the exercise at the point below the umbilicus 
(dantien) and feel as if this point were increasing slightly. After focusing the attention in the 
shoulder region and shoulder blades (Crass Intestinal passage of the conduit). Feel this 
region to relax. During vibration perform a technique where imagination is thought that the 
body is wrapped in a thick film and that this film during vibration will be broken and will 
dropped, with the body becoming loose. 
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9.Clarity of the sky 
Standing with arms along the body, start the exercise by lifting them with your palms 
facing upwards raising the arms to the top of the head. When the arms are raised already, 
imagine that a very strong and bright light will be collected by us and as the arms go down, 
with the palms facing down, this light will envelop the whole body and brings a sense of 
welfare. At a later stage, explain the existence of PC8 point and repeating the same exercise 
focusing attention on this point, and assuming that it expands and increases with this light 
and provides better clarity in the entry of this same body. 
 
10. The Horse. Standing in Qigong position. Palms of the hands turning to the earth 
in the level of the belly boton ( dantian region). Standing during 8 breathing. 
11. Standing  
Repetion of the second exercise. 
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4. OUTCOMES 
 
Based on a preliminary study conducted at Hospital São João (Porto) and Hospital 
of Vila Nova de Gaia / Espinho, in the context of the thesis master's degree in TCM in 
University of Porto by Irene Pais with the Titlle- Effect of Acupuncture on NK cells in patients 
with colorectal cancer undergoing chemotherapy, we expect to have positive results in this 
study. 
 
4.1 - MAIN PARAMETERS 
 
The following cellular components were quantified in all patients, leukocyte, 
neutrophil, total lymphocytes, T and B lymphocytes and NK cells. Every blood sample was 
taken directly to the laboratory at most two hours after being harvested. 
The samples of blood were collected from two different ways. When patients need 
to take blood samples for the hospital protocol, the investigator ask to the department of 
"Central de Colheitas" to take one more blood sample for the investigation study, 
respectively T1 and T3. In the other moments, T0 and T2, the blood was collected by the 
investigator (nurse in IPO) at a room on the "Clinica De Patologia Digestiva". The necessary 
analyses to the study was performed at the laboratory of Immunology, in Centro Hospitalar 
do Porto, under the supervision of Dr. Esmeralda Neves. 
 
4.2 - SECONDARY PARAMETERS 
It was collected data from socio-demographic and clinical questionnaires, such as 
diagnosis clinical time and medical treatment, as well as data from Hospital Anxiety and 
Depression Scales” (HADS) – Portuguese version and from EORTC QLQ 30- and QOL-
CR29. with the aim to assess the anxiety and depression levels as well as the patients' 
quality of life. 
 “Hospital Anxiety and Depression Scales” (HADS) - the Portuguese version 
validated by Pais Ribeiro et al. "Hospital Anxiety and Depression Scales": Scale 
developed by Zigmond and Snaith (1994), with the aim of assess levels of anxiety 
and depression in patients with physical diseases and ambulatory treatment. It takes 
approximately five minutes to complete [67]. Was validated for the Portuguese 
context by Pais-Ribeiro et al (2007). It consists of 14 items which are divided into 
two subscales: anxiety (7 items) and depression (7 items). The items reflect a state 
of generalized anxiety and the depression items are associated with a state of 
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anhedonia. Response options vary between zero and three in a Likert scale of 4 
points. [67]. 
 "European Organization for Research and Treatment of Cancer Quality of Life 
Questionnaire" (EORTC QLQ 30): Instrument created by the European Organization 
for Research and Treatment of Cancer Quality of Life [68]. The QLQ-C30 aims to 
assess relevant aspects for any cancer patient regardless of the neoplasia to 
assess, not responding to the specific situation in each type of neoplasia [71]. It 
consists of five functional scales (physical, performance, cognitive, emotional and 
social), three symptom scales (fatigue, pain, nausea and vomiting) overall health 
status, 6 simple items to assess additional symptoms or problems (dyspnea, loss of 
appetite, insomnia, financial difficulties, constipation and diarrhea) [71]. The items 
correspond into worse QOL [71]. 
 
4.3 - STATISTICAL ANALYSIS 
This study was designed to provide preliminary data to inform the design and 
analysis of a subsequent large-scale, fully powered study to evaluate the effects of Qigong 
on NK cells in patients with CRC. However due to the obtained reduced sample size, it was 
not possible to perform statistical analyses. So it will be discussed case studies. 
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III- RESULTS 
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5. BASELINE CHARACTERISTICS - SAMPLE CHARACTERIZATION 
  
At baseline, all patients were characterized based on demographic and clinical 
characteristics (Table 6 and 7).  
In the experimental group, the patients mean age is 51.7 years; 66.66% of patients are 
female and have colon cancer diagnosis and 33,33% are male and are diagnosed with 
rectal cancer. All patients are under FOLFOX CT regimen. 33.33% have a T4B cancer 
stage, 33.33% T3 stage with distant metastasis and T3 with local ou distant metastasis 
(Table 6). 
The control group, the mean age is 51.7 years; 66,66% of patients are male with a 
diagnosis of rectal cancer  and 33,33% are female and diagnosed with colon cancer. 
66.66% of patients are undergoing  FOLFOX CT regimen and 33.33% are under Degramon 
regiment. 33.33% of these patients have a T2 cancer stage and 66.66% have a T3 cancer 
stage with local (lymphatic nodes) metastasis. (Table 7). 
 
 
 PATIENT 1 PATIENT 2 PATIENT 3 
AGE 53 57 45 
SEX Female Male Female 
RESIDENCE Porto Porto Porto 
DIAGNOSIS Sigmoid colon 
Adenocarcinome  
Retal cancer Ascending colon 
adenocarcionome 
TYPE OF CT adjuvant Ct folfox adjuvant Ct folfox adjuvant Ct folfox 
STAGE T4B,N0,M0 T3,N2,M1 T3,N0,M0 
Table 6.  Experimental Group: Socio-demographic and clinical characteristics. 
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 PATIENT 1 PATIENT 2 PATIENT 3 
AGE 42 51 62 
SEX Male Male Female 
RESIDENCE Porto Porto Porto 
DIAGNOSIS Retal Adenocarcinoma Retal adenocarcinoma Adenocarcionoma 
colon sigmoide 
TYPE OF CT Ct adjuvante folfox Ct adjuvante 
Degramon 
Ct adjuvante folfox 
STAGE T2,N0,M0 T3,N2,M0 T3,N1B,M0 
Table 7. Control, Group: Socio-demographic and clinical characteristics.  
 
Comparison of blood analyses at baseline showed that blood values are similar in 
both groups, except for B and NK cells that are in higher ammounts in the control group 
patients (Table 8). 
 
 
EXPERIMENTAL GROUP 
(N=3) 
BASELINE BLOOD 
ANALYSES 
(MEAN) 
CONTROL GROUP 
(N=3) 
4566,6 WBC (MM3) 6266 
2433,3 ANC (MM3) 2466,6 
1633,3 TOTAL LYMPHOCYTE (MM3) 1666,6 
219,06 B CELLS (MM3) 490 
1298,3 T CELLS (MM3) 1008,6 
115,54 NK CELLS (MM3) 167,15 
Table 8. Blood analyses at baseline. Comparison between groups. 
 
 
A total of 5 (83,3%) patients completed the questionnaires of QOL-CR29 and 30 and 
HDAS at the beginning of the study (table 9). Comparison of anxiety and depression 
between both groups, reveal that levels were higher in the control group, before the study. 
The remaining results do not allow to make a general safe comparison because of the 
diversity of results. However, nausea/vomit, diarrohea and constipation do not show any 
symptoms in both groups. 
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EXPERIMENTAL 
GROUP 
(N=3) 
BEFORE 
QOL CR 29, C30 AND HADS 
SCORES 
(MEAN) 
CONTROL GROUP 
(N=3) 
  BEFORE 
8,33 ANXIETY 9 
7 DEPRESSION 8 
0 DISURIA SYMPTOMS 0 
2 BLOOD IN STOOL SYMPTOMS 3,7 
0 URINARY INCONTINENCE 0 
1,3 ABDOMINAL PAIN 2 
2 BLOATING 2 
2 DRY MOUTH 2 
2,3 TASTE 2 
1,3 FLATULENCE 1,3 
0 FAECAL INCONTINENCE 1,3 
0,3 IMPOTENCE 0 
0 DYSPAREUNIA 0,3 
0,6 STOMA-RELATED SYMPTOMS 0 
0 MALE SEXUAL FUNCTION 1,6 
0 FEMALE SEXUAL FUNCTION 0,3 
3 WEIGHT CONCERNS 2,6 
6 BODY IMAGE 4,6 
4,7 PHYSICAL FUNCTIONS 4 
4,6 ROLE FUNCTION 4 
7 EMOTIONAL FUNCTION 5 
2 COGNITIVE FUNCTION 0,7 
3,3 SOCIAL FUNCTION 4 
7,3 FATIGUE 4 
0 NAUSEA/VOMIT 0 
3 PAIN 1,3 
0,7 DYSPNOEA 0 
3 INSOMNIA 1,3 
0,7 LOSS OF APETITE 0 
0 CONSTIPATION 0 
0 DIARRHOEA 0 
1,3 FINANTIAL ISSUES 2,3 
9 HEALTH OWN PERCEPTION 9,7 
 
Table 9. QOL CR-29, 30 and HADS scores. Comparison between groups at baseline. 
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6. RESULTS OF THE QIGONG ON THE IMMUNE SYSTEM – MAIN 
PARAMETERS 
 
 
Effect of Qigong on WBC 
 
WBC were improved in two patients of the experimental group and on the control 
group only one patient have showed improved levels of these cells types (Figure 1 and 2). 
 WBC improved in all patients at nadir time points T2, in comparison to nadir time point 
T0:patient 1, 9100cell/mm3 (T2) vs 4600 cell/mm3 (T0); patient 2, 4000 cell/mm3 VS 3500 
cell/mm3 and patient 3, 6300 cell/mm3 VS 5600. 
In respect to recovery days (T3 vs T1), our results show that WBC were higher at 
T3 only in one patient (patient 2), 5600 vs 5400, suggesting that Qigong may have little 
effect on immunity recovery. However, when comparing WBC at the beginning and at the 
end of the study, only one of the patients (patient 3) in the experimental group had a slight 
decreased of these cells. In contrast, control group results shows that only one patient 
(patient 1) have had WBC higher in the end of the study than in the beginning. Moreover, 
one of the patients (patient 3) stopped the chemotherapy because of low values of WBC at 
recovery day (1800 cell/mm3), and consequently dropped out of the study. 
 
 
Figure 15. Experimental Group: WBC analyses 
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Figure 16. Control Group: WBC analyses 
 
 
Moreover, when comparing experimental and control groups at baseline for WBC 
we found that patients on the control group have higher counts of these cells and that at the 
end of the study the experimental group have higher counts. Thus, it seems that Qigong 
have a myeloprotective effect (leukopenia). 
 
 
 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 4533.3 6266 
T3 (N=5) 5800 5200 
Table 10. Comparison of baseline and end of study WBC counts (means-cell/mm3) between groups 
(experimental and control) 
 
 
Effect of Qigong on ANC 
 
ANC were improved in two patients of the experimental group and on the control 
group only one patient have showed improved levels of these cells types (Figure 3 e 4). 
ANC at T2 were improved in all patients of experimental group and in control group only 
one patient showed elevated levels. At recovery day T3 no significant results on ANC were 
observed in the experimental group, only one patient showed higher levels of ANC 
comparing to T1. 
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Figure 17. Experimental Group: ANC analyses. 
 
Figure 18. Control Group: ANC analyses. 
 
Comparing the experimental and control groups at baseline for ANC we found that 
both groups have similar numbers of ANC. However, at T3, the experimental group has 
revealed a significant increase of ANC when comparing to the control group that only slightly 
increase of ANC.  
 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 2433,3 2466,6 
T3 (N=5) 3200 2600 
Table 11. Comparison of baseline and end of study ANC counts (means-cell/mm3) between groups 
(experimental and control) 
 
 
 
 
2500
4600
5400
3900
1800
3100 2300
34003000
3400 3300
2300
0
1000
2000
3000
4000
5000
6000
t0 t1 t2 t3
2400
3300
2100
3500
3600
1400
12800
1700
1400 3000
2000
4000
6000
8000
10000
12000
14000
t0 t1 t2 t3
Patient 1
Patient 2
Patient 3
EFFECT OF QIGONG IN NATURAL KILLER CELLS ON COLO-RECTAL CANCER PATIENTS UNDERGOING FOR 
CHEMOTHERAPY 
 
 
76 
 
 
Effect of Qigong on Total lymphocytes and subsets 
 
Total Lymphocites were improved in two patients (patient 1 and 2) on the 
experimental group comparing the results between T0 and T3. (Figure 5). The oposit 
happened in the control group that in two patients (patient 2 and 3) the results decrease in 
the same evaluation. 
 
 
Figure 19. Experimental Group: Total lymphocytes analyses. 
 
Figure 20. Control Group: Total lymphocytes analyses 
 
Additionally, when comparing experimental and control groups at baseline (T0)  and 
T3 for total lymphocytes, we found that both groups have had a small increase in the results. 
Control group have a increase of 8% and the experimental group an increase of 4%. 
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 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 1633,3 1666,6 
T3 (N=5) 1700 1800 
Table 12. Comparison of baseline and end of study total lymphocytes counts (means-cell/mm3) between 
groups (experimental and control) 
 
 
 
Effect of Qigong on B cells and subsets 
 
In respect to B cells counts, results shows that two patients on the experimental 
group have higher B cells counts in the end of the study that in the begining. Moreover, 
when comparing nadir time points we found that in two patients the B cells counts were 
higher in the second nadir (T2) relatively to the first nadir (T0). At recovery days we found 
that the second recovery day (T3) have lower B cells counts than the first (T1) in two 
patients. Only one patient (patient 2) showing higher B cells counts at T3 when compared 
to T1. 
 In the control group, patient 3 drop out of the study at T1 due to low levels of WBC. Thus 
only two patients were fully evaluated until the end of the study. These two patients showed 
decreased values of B cells at the end of the study (T3), when compared to the beginning 
(T0) (Figure 8).  
 
 
Figure 21. Experimental group: B cells counts. 
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Figure 22. Control group: B cells counts. 
 
Comparing experimental and control groups at baseline and T3 we can conclude 
that in both groups the B cells decrease. However, in the control group the B cells registered 
a decrease of 54,2%, comparing with the decrease of  18,61% obtained in the experimental 
group. Thus, it seems that Qigong have a protective effect on this cells. 
 
 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 219,06 490,27 
T3 (N=5) 178,3 224,65 
Table 13. Comparison of baseline and end of study B cells counts (means-cell/mm3) between groups 
(experimental and control) 
 
 
Effect of Qigong on T cells and subsets 
 
T cells only raised in one patient (patient 2) and keeped similar in patient 1, when 
comparing values at the end and at the begining of the study. At nadir time points, we found 
higher values in T2 relatively to T0 in all patients and at recovery days only one patient have 
show higher T cells counts at T3 than T1; however T cells counts on the other two patients 
were very similar at recovery days (Figure 9). 
 In the control group, only one patient showed an increased T cell counts since the begining 
of the study until the end (patient 2). Patient 1 showed a slight decrease of these cells when 
comparing T3 to T0; however T cells counts on these patient were quit stable at nadir time 
points and at recovery days also (Figure 10). 
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Figure 23. Experimental group: T cells counts. 
 
Figure 24. Control group: T cells counts. 
 
When comparing experimental and control groups at baseline for T cells we found 
that patients on the control group have higher counts of these cells on T3 than in baseline. 
We can compare with the experimental group, that also have a increase of the results, 
however, in control group at the end of the study the results are slightly higher. 
 
Table 14. Comparison of baseline and end of study T cells counts (means-cell/mm3) between groups 
(experimental and control) 
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 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 1298,3 624,6 
T3 (N=5) 1301,5 1353,6 
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Effect of Qigong on NK cells 
 
Our results showed that NK cells counts were higher in the end of the study 
compared to the beginning. Moreover, in respect to nadir time points results shows higher 
counts ok NK cells at T2 vs T0. At recovery days, except for patient 2, NK cells were also 
in higher numbers than in T1 (Figure 11).  
In the control groups it was also verified an increased NK cells counts at the end of 
the study when compared to the begining, in two patients (Figure 12).  
 
 
Figure 25. Experimental group: NK cells counts. 
 
 
Figure 26. Control group: NK cells counts 
 
Making the corresponding between experimental and control groups at baseline for 
NK cells we found that patients of the both groups have increase of these cells. However, 
the magnitude of the NK cells in the experimental group is much higher than in the control 
group, since there are a few differences on NK cells baseline counts between the  
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experimental group(140.8, 99.84, 106 cell/mm3) and the control group (220.8, 166.4, 
114.25 cell/mm3). 
 
Table 15. Comparison of baseline and end of study NK cells counts (means-cell/mm3) between groups. 
 
 
 
7. EFFECT OF QIGONG ON PATIENTS QOL, ANXIETY AND DEPRESSION 
SCALES – SECUNDARY PARAMETERS 
 
 
In concern of the secondary parameters of evaluation of this study, a total of  5 
(83,3%) patients completed the questionnaires of QOL-CR29, QOL-CR30  and HADS at 
the beginning and at the end of the study. 
The QLQ – CR30 is considered a questionnaire for assessing QOL in patients with 
cancer, consisting of 30 items, divided by a global scale, five functional scales (physical, 
role, emotional, cognitive and social functioning), and sub-scales of symptoms associated 
with cancer and treatment. It is a questionnaire considered appropriate for use with cancer 
patients from the moment of diagnosis to long survivorship (Table 3). 
 EXPERIMENTAL GROUP CONTROL GROUP 
BASELINE (N=6) 115,54 167,15 
T3 (N=5) 219,73 220,92 
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Table 16. Items/Subscales of QLQ-CR30 questionnaire 
 
A. QLQ-CR30 QUESTIONNAIRE- FUNCTIONAL SCALES: 
 
 
  Figure 27: Experimental group.  Functional scales assessed by QLQ-CR30 questionnaire. 
           Legend:EXP- experimental group patient; BEF- Before; AFT- After. 
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               Figure 28. Control group.  Functional scales assessed by QLQ-CR30 questionnaire.  
              Legend: CTR- Control group patient; BEF- Before; AFT- After. 
 
 
 
All of the functional scales in experimental group were enhanced after Qigong 
treatment. Emotional functions were those that presented most improvement. Social 
functions didn’t have any change before and after the study except in patient 3 that slightly 
improve after the treatment. In the control group, results shows that across the time the 
most affected functions are in patients 1 in emotional functions that decrease and in patient 
2 that physical function decrease more than the other parameters. All the other functional 
scales slightly decrease. 
Thus, our results suggest that Qigong is able to act on cancer patients most affected 
functional scales (physical and emotional) as well as on improvement of cognitive and social 
functions. 
 
 
 
 
 
 
 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
18
20
CTR1
BEF
CTR1
AFT
CTR2
BEF
CTR2
AFT
CTR3
BEF
CTR3
AFT
Functional Scale - Ctr. group
Physical Function
Role Function
Emotional Function
Cognitive Function
Social Function
EFFECT OF QIGONG IN NATURAL KILLER CELLS ON COLO-RECTAL CANCER PATIENTS UNDERGOING FOR 
CHEMOTHERAPY 
 
 
84 
 
 
B. QLQ-CR30 QUESTIONNAIRE- SYMPTOMS SCALES 
 
 
                  Figure 29. Experimental Group , Symptoms scales assessed by QLQ-CR30 questionnaire.  
                  Legend: EXP, Experimental group patient; BEF,  Before; AFT, After. 
 
 
        Figure 30. Control Group , Symptoms scales assessed by QLQ-CR30 questionnaire. 
        Legend: CTR, Control group patient ; BEF- Before; AFT- After. 
 
 
All patients of the both groups have a good health own perception experienced. 
Symptoms as nausea and vomit, constipation and diarrhoea don’t have been manifested .  
The results on the experimental group show an improvement on fatigue and all of 
the patients also experienced a decrease on insomnia  and loss of appetite symptoms.  
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In contrast, symptomatic scales on the control group patients remained unchangable 
for nausea/vomit, dyspnea, constipations, diarrhea. Symptoms such us fatigue are those 
you decrease more in the control group. 
 
QLQ-CR29 is a specific module for colorectal cancer patients varying in disease 
stage and treatment modality (i.e. radiotherapy or chemoradiation,ultra-low anterior 
resection, minimal access surgery and new chemotherapy regimens). It is divided into two 
major groups of subscales (Table 4). The answer to each of these items is also given 
through a likert scale with four alternatives in which the extremes are “not at all” and “very 
much”. 
 
 
            Table 17 . Items/Subscales of QLQ-CR29 questionnaire. 
 
 
C. QLQ-CR29 QUESTIONNAIRE- FUNCTIONAL SCALES 
 
With regard to evaluation after qigong intervention, in experimental group, the score 
has improved in the Body image score in all of the tree patients (Graphic 15). It is also at 
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the level of Weight functioning the score has improve in two of the tree patients. In turn, in 
control group (Graphic 16), the levels of anxiety are higher in one patient, comparing to the 
experimental group that maintained equal before and after the intervation.  
 
Figure 31: Experimental group:  functional scales assessed by QLQ-CR29.  
Legend: PT, patient ; B- body 
 
 
Figure 32:  Control group:  functional scales assessed by QLQ-CR29. 
 Legend: PT, patient ; B- Body 
 
 
D .QLQ-CR29 QUESTIONNAIRE- SYMPTOMS SCALES 
 
In concern of the evaluation of the symptoms scale of the both groups we can 
conclude that symptoms are not the most relevant factores that have evidence of Qigong 
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therapy. However, we could see some slightly changes between before and after the 
treatment in the both groups. In experimental group, the abdominal pain,stool frequency 
and dry moth have a significant decrese of the results (patient3). Patient 2, have a increase 
of the stool frequency after the study. The other symptoms maintained the same values 
during the study in the other patients. 
 
 
 
 
Figure 33. Experimental group:  symptomatic scales assessed by QLQ-CR29.  
Legend: Exp, experimental group patient; AFT, after; Bef, before. 
 
Regarding to symptoms items/subscales of the control group, it is shown that there 
was an aggravation of dry mouth and abdominal pain. The other symptoms maintained the 
al most the same values during the study in the other patients. 
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Figure 34. Control group:  symptomatic scales assessed by QLQ-CR29.  
Legend: CRT- control group patient; AFT- after; Bef - before. 
 
 
E. EFFECTS OF QIGONG ON ANXIETY AND DEPRESSION LEVELS - HADS 
 
The parameters of the evaluation of this scale (anxiety and depression of the 
patients) are significantly different from the both groups. In concern of anxiety control 
group show in patient 2 a increase of anxiety. The other patients maintained the same 
results. In experimental group the anxiety was noticeably reduced in all the patients. On 
the other hand, in depression scale, in control group just one patient have decrease the 
levels, the others increase the score of depression, comparing to the experimental group 
that all of the patients have decrease depression score. 
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             Figure 35. Anxiety and depression scale. HADS 
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8. DISCUSSION 
 
This study is part of a global trend of clinical management and health research that 
begins to encourage the integration of complementary therapies in health care for cancer 
patients.  
The functional state of the host immune system has a major prognostic and 
predictive impact on the fate of cancer patients treated with conventional or targeted 
chemotherapies. 
Studies on CRC tumourigenesis and prognosis, showing that NK cell migration into 
tumour tissue is impaired in early stages of tumour development and that NK cells activity 
is reduced in metastatic CRC lead to conclude that NK cells have a pivot role on CRC 
tumourigenesis and being a first line of defense against metastasis. Moreover, Grivennikov 
et al revealed that the presence of NK cells in tumour immune microenvironment represents 
a positive prognostic marker, being the unique cells without a pro-tumourigenic role. 
There is a lack of data regarding the effect of Qigong in immunity on cancer patients. 
In fact, only one study reported increased levels of WBC, RBC and NK cells. 
To our knowledge, this is the most actual study on Qigong immunomodulation in 
CRC conducted in the West. Although, our results must be interpreted cautiously, due to 
small samples sizes, however we found trends of higher WBC and NK cells in the Qigong 
group relative to control group of patients with CRC undergoing chemotherapy. 
Our results suggest that Qigong may have a myeloprotective role by reducing the 
rates of leukopenia and neutropenia in CRC patients undergoing chemotherapy. Moreover, 
our results suggests that Qigong is able to stimulate anticancer immunity through the 
augmentation of NK cells numbers on these patients.  
Our results are in agreement in another one (Cai e al, 2001) that reported that qigong 
was able to highly improve patients immunity, specially WBC and NK cells. 
Relativly to the QOL, patients show that in experimental group the anxienty and 
depression as well as chemotherapy effects are decrease comparing to the control group. 
Further studies are needed to confirm these preliminary data as well as to compare 
if Qigong effects on CRC patients immunity and QOL are similar to those obtained with 
acupuncture and moxibustion (Pais et al 2014),  namely the reduction of leukopenia and 
neutropenia rates in 1,5x, myeloprotective and immunoregulatory effects. And also to 
assess the effect of combined Qigong and acupuncture plus moxibustion on CRC patients. 
We can still discuss about certain limitations that emerged along of the study and 
may be consider such as reduced sampling - It is necessary to carry out a study with a 
larger sample, to allow precise evaluation of the effect of Qigong in patients with CRC 
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undergoing chemotherapy, the short duration of the study did not allow more precise data 
on the impact of Qigong treatments in the parameters of immunity and quality of life of 
patients at a later stage to treatment (follow-up). 
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9. CONCLUSION 
 
The present results suggest that Qigong not only improves the general condition of the 
patient as regards the quality of life and mental status, and is also associated with 
improvement of the immune system. 
In this context, this clinical research protocol is unique with respect to its objectives and 
evaluation methods. 
Our clinical research protocol  is a pilot study, however revealed that Qigong treatment 
according to the Heidelberg Model of Traditional Chinese Medicine : 
- may have a effect on immunity recovery; 
- have a myeloprotective effect (leukopenia). 
- improve the quality of life and general health of patients; 
- improve the psycho-emotional state of patients, since there was a reduction in levels 
of anxiety and depression. 
 
This research may have contributed to the production of new scientific knowledge in the 
field of complementary treatments in oncology and clarify whether a low-cost and no side 
effects therapy may help to improve the overall results of the multidisciplinary cancer 
treatment.  
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